Case number 2:16-cv-02525
Amarin Pharma Inc. et al v. Hikma Pharmaceuticals USA Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 14, 2022 | 421 | RECEIPT for Exhibits released to Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited on 7/14/2022. (KF) (Entered: 07/14/2022) (0) |
| Jul 13, 2022 | 420 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 7/13/2022. By Deputy Clerk: Peggie Vannozzi. The court currently has custody of exhibits in this action in its Reno division. It has been determined these exhibits can be returned to the parties. IT IS ORDERED that the parties have 21 days from the date of this order to claim the exhibits from the clerk under Local Rule 79-1 or exhibits shall be destroyed. Please contact the Clerk's Office in Reno at (775) 686-5800 to make arrangements to have the exhibits picked up or said exhibits shall be destroyed by the court. Deadline to return exhibits set for 8/3/2022. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 07/13/2022) (0) |
| Mar 29, 2022 | 419 | ORDER on Mandate as to 413 Notice of Appeal, filed by EPA Drug Initiative II. Signed by Chief Judge Miranda M. Du on 3/29/2022. (Copies have been distributed pursuant to the NEF - LG) (Entered: 03/29/2022) (0) |
| Mar 24, 2022 | 418 | MANDATE of USCA, Federal Circuit, as to ECF No. 417 USCA Judgment affirming USDC. USCA Fed. Ckt. Case No. 21-2024. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/24/2022) (0) |
| Feb 15, 2022 | 417 | JUDGMENT of USCA, Federal Circuit, as to ECF No. 413 Notice of Appeal. USDC AFFIRMED. Mandate to issue in due course. USCA Fed. Ckt. Case No. 21-2024. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 02/15/2022) (0) |
| Jun 8, 2021 | 416 | USCA, Federal Circuit Appellate Case Number 2021-2024 assigned to 413 Notice of Appeal,. (DRS) (Entered: 06/09/2021) (0) |
| Jun 7, 2021 | 415 | TRANSCRIPT DESIGNATION by Intervenor Plaintiff EPA Drug Initiative II re 413 Notice of Appeal,. Transcripts are NOT required for this appeal. (Kasanoff, Michael) (Entered: 06/07/2021) (0) |
| May 21, 2021 | 414 | FORMS - Designation of Transcripts and Transcript Order forms and instructions for ECF No. 413 Notice of Appeal. Forms may also be obtained on the Court's website at www.nvd.uscourts.gov. (Attachments: # 1 Transcript Order Form) (KR) (Entered: 05/21/2021) (0) |
| May 20, 2021 | 413 | NOTICE OF APPEAL as to 412 Order on Motion to Intervene,, Order on Motion to Vacate,,, by Intervenor Plaintiff EPA Drug Initiative II. Filing fee $ 505, receipt number 0978-6494996. E-mail notice (NEF) sent to the Federal Circuit Court of Appeals. (Kasanoff, Michael) (Entered: 05/20/2021) (0) |
| May 20, 2021 | 413 | Notice of Appeal* (1) |
| Apr 30, 2021 | 411 | ORDER APPROVING ECF No. 402 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Michael S. Kasanoff for EPA Drug Initiative II and approving Designation of Local Counsel Jakub Medrala. Signed by Chief Judge Miranda M. Du on 4/30/2021. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - DRM) (Entered: 04/30/2021) (0) |
| Apr 30, 2021 | 412 | ORDERED that EPA Drug Initiative II's motion to intervene (ECF No. 401 ) is denied. It is further ordered that EPA Drug Initiative II's motion to vacate (ECF No. 405 ) is denied. Signed by Chief Judge Miranda M. Du on 4/30/2021. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 04/30/2021) (0) |
| Apr 8, 2021 | 410 | REPLY to Response to 401 Motion to Intervene, 405 Motion to Vacate, by Intervenor Plaintiff EPA Drug Initiative II. (Attachments: # 1 Declaration, # 2 Index, # 3 Exhibit, # 4 Exhibit, # 5 Exhibit, # 6 Certificate of Service) (Medrala, Jakub) (Entered: 04/08/2021) (0) |
| Apr 1, 2021 | 408 | RESPONSE to 401 Motion to Intervene, 405 Motion to Vacate, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 4/8/2021. (Hosmer-Henner, Adam) (Entered: 04/01/2021) (0) |
| Apr 1, 2021 | 409 | RESPONSE to 401 Motion to Intervene, by Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited. Replies due by 4/8/2021. (Allen, W.) Modified on 4/2/2021 to reflect additional filing parties (MMM). (Entered: 04/01/2021) (0) |
| Mar 19, 2021 | 401 | MOTION to Intervene by Intervenor Plaintiff EPA Drug Initiative II. Responses due by 4/2/2021. (Attachments: # 1 Index, # 2 Exhibit, # 3 Exhibit, # 4 Exhibit, # 5 Declaration, # 6 Certificate of Service) (Medrala, Jakub) (Entered: 03/19/2021) (0) |
| Mar 19, 2021 | 402 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Michael S. Kasanoff and DESIGNATION of Local Counsel Jakub P. Medrala (Filing fee $ 250 receipt number 0978-6412684) by Intervenor Plaintiff EPA Drug Initiative II. (Medrala, Jakub) (Entered: 03/19/2021) (0) |
| Mar 19, 2021 | 403 | NOTICE of Appearance by attorney Jakub P Medrala on behalf of Intervenor Plaintiff EPA Drug Initiative II. (Medrala, Jakub) (Entered: 03/19/2021) (0) |
| Mar 19, 2021 | 404 | CERTIFICATE of Interested Parties by EPA Drug Initiative II. There are no known interested parties other than those participating in the case (Medrala, Jakub) (Entered: 03/19/2021) (0) |
| Mar 19, 2021 | 405 | MOTION to Vacate 382 Judgment by Intervenor Plaintiff EPA Drug Initiative II. (Attachments: # 1 Index, # 2 Exhibit, # 3 Exhibit, # 4 Exhibit, # 5 Exhibit, # 6 Exhibit, # 7 Exhibit, # 8 Declaration, # 9 Certificate of Service) (Medrala, Jakub) (Entered: 03/19/2021) (0) |
| Mar 19, 2021 | 406 | NOTICE: Attorney Action Required to 402 Motion for Permission to Practice Pro Hac Vice - Verified Petition. The appointment of local counsel requires the signatures of the parties and not of the attorney seeking admission pro hac vice. Attorney Michael Kasanoff is advised to obtain the signatures of the authorized signatory of his clients and to refile his petition using the Notice of Corrected Image/Document event under the Notices category. Petitioner must link to the corrected image to his original pro hac vice motion (ECF No. 402 .) Compliance due by 3/29/2021. (no image attached) (PAV) (Entered: 03/19/2021) (0) |
| Mar 19, 2021 | 407 | NOTICE of Corrected Image/Document re 402 Motion for Permission to Practice Pro Hac Vice - Verified Petition, 406 Notice Attorney Action Required,, by Intervenor Plaintiff EPA Drug Initiative II. (Service of corrected image is attached.) (Medrala, Jakub) (Entered: 03/19/2021) (0) |
| Nov 16, 2020 | 399 | COSTS TAXED in the amount of $ 56,018.57 against Amrin Pharma, Inc., in favor of Hikma Pharmaceuticals USA Inc. and Hikma Pharmaceuticals Int'l Ltd.. See Order ECF No. 392 . (DRM) (Entered: 11/16/2020) (0) |
| Nov 16, 2020 | 400 | COSTS TAXED in the amount of $ 46,935.23 against Amrin Pharma, in favor of Dr. Reddy's Laboratories, Inc.; Dr. Reddy's Laboratories, Ltd. See Order ECF 392 . (DRM) (Entered: 11/16/2020) (0) |
| Nov 13, 2020 | 398 | ORDER on Mandate as to ECF Nos. 394 USCA Judgment and 396 USCA Mandate. USCA Federal Circuit Court of Appeals Case Numbers 2020-1723, 2020-1901. Signed by Chief Judge Miranda M. Du on 11/13/2020. (Copies have been distributed pursuant to the NEF - AB) Modified on 11/13/2020 to remove "USCA" and denote Federal Circuit Court Case Numbers. NEF regenerated (AB). (Entered: 11/13/2020) (0) |
| Nov 12, 2020 | 396 | MANDATE of USCA, Federal Circuit, as to 394 USCA Judgment. AFFIRMED. (Copies have been distributed pursuant to the NEF - HAM) (Entered: 11/12/2020) (0) |
| Nov 4, 2020 | 395 | ORDER of USCA, Federal Circuit Ninth Circuit , as to 383 Notice of Appeal. IT IS ORDERED THAT the petition for panel rehearing is denied. The petition for rehearing en banc is denied. The mandate of the court will issue on November 12, 2020. (Copies have been distributed pursuant to the NEF - HAM) Modified on 11/13/2020 document from Federal Circuit not the 9th Circuit. (WJ). (Entered: 11/04/2020) (0) |
| Sep 3, 2020 | 394 | JUDGMENT of USCA, Federal Circuit, as to 383 Notice of Appeal, filed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc. (Copies have been distributed pursuant to the NEF - HAM) (Entered: 09/03/2020) (0) |
| May 4, 2020 | 393 | TRANSCRIPT DESIGNATION by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited re 383 Notice of Appeal, 121 Markman/Claim Construction Hearing,,,,,,,,,, 307 Order on Motion to Compel,,,,,,,,,,,,, Pretrial Conference,,,,,,,,,,,, 348 Bench Trial,,,, 367 Transcript,, 347 Bench Trial,,, 308 Transcript,, 358 Bench Trial,,,,,,,, 370 Transcript,, 365 Transcript,, 371 Transcript,, 356 Bench Trial,,, 369 Transcript,, 366 Transcript,, 354 Bench Trial,,, 355 Bench Trial,,,, 351 Bench Trial,,, 368 Transcript,,. (Hosmer-Henner, Adam) (Entered: 05/04/2020) (0) |
| May 1, 2020 | 391 | STIPULATION Regarding Bills of Costs re 387 Bill of Costs, 388 Bill of Costs, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Finkelstein, Beth) (Entered: 05/01/2020) (0) |
| May 1, 2020 | 392 | ORDER granting ECF No. 391 Stipulation. The Stipulation regarding bills of costs (ECF Nos. 387 and 388 ) is approved. (See PDF image for additional details). Signed by Chief Judge Miranda M. Du on 5/1/2020.(Copies have been distributed pursuant to the NEF - AB) Modified on 5/12/2020 (LG) ORD taxation of costs to be entered after completion of appeal. (Entered: 05/04/2020) (0) |
| Apr 21, 2020 | 390 | USCA NOTICE of Docketing to appellant re ECF No. 383 Notice of Appeal. USCA, Federal Circuit Case No. 20-1723 assigned. (LW) (Entered: 04/21/2020) (0) |
| Apr 20, 2020 | 386 | ORDER granting 385 Stipulation to extend time to File Bill of Costs by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc. Bill of Costs due by 4/20/2020. Signed by Chief Judge Miranda M. Du on 4/14/2020.(no image attached)(Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/20/2020) (0) |
| Apr 20, 2020 | 387 | BILL OF COSTS by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Objection to Bill of Costs due by 5/4/2020. Tax Bill of Costs by 5/11/2020. (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Finkelstein, Beth) (Entered: 04/20/2020) (0) |
| Apr 20, 2020 | 388 | BILL OF COSTS by Counter Claimant Hikma Pharmaceuticals USA Inc., Defendant Hikma Pharmaceuticals USA Inc.. Objection to Bill of Costs due by 5/4/2020. Tax Bill of Costs by 5/11/2020. (Attachments: # 1 Exhibit A, # 2 Exhibit B) (Heydorn, Alison) (Entered: 04/20/2020) (0) |
| Apr 20, 2020 | 389 | MEMORANDUM to 387 Bill of Costs, 388 Bill of Costs, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Attachments: # 1 Declaration Beth C. Finkelstein, # 2 Declaration Alison M. Heydorn) (Finkelstein, Beth) (Entered: 04/20/2020) (0) |
| Apr 13, 2020 | 385 | First STIPULATION FOR EXTENSION OF TIME (First Request) Stipulation to Extend Date to File Bill of Costs by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Rounds, Michael) (Entered: 04/13/2020) (0) |
| Apr 3, 2020 | 384 | Designation of Transcripts and Transcript Order forms and instructions for ECF No. 383 Notice of Appeal. The forms may also be obtained on the Court's website at www.nvd.uscourts.gov. (Attachments: # 1 Transcript Order Form) (AB) (Entered: 04/03/2020) (0) |
| Apr 2, 2020 | 383 | NOTICE OF APPEAL as to 135 Order, 278 Order on Motion for Partial Summary Judgment,,,,, Order on Motion to Seal,,,,, Order on Motion for Summary Judgment,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 381 Order,, 382 Judgment by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Filing fee $ 505, receipt number 0978-5951560. E-mail notice (NEF) sent to the Federal Circuit Court of Appeals. (Hosmer-Henner, Adam) (Entered: 04/02/2020) (0) |
| Apr 2, 2020 | 383 | Notice of Appeal* (1) |
| Mar 30, 2020 | 381 | BENCH ORDER - The Court finds that Defendants' proposed ANDA Products will induce infringement of the Asserted Claims, but all the Asserted Claims are invalid as obvious under 35 U.S.C. § 103. Thus, the Court finds in favor of Defendants on Plaintiff's remaining infringement claim, and in their favor on their counterclaims asserting the invalidity of the Asserted Claims under 35 U.S.C. § 103. The Clerk of Court is ordered to enter judgment in favor of Defendants on Plaintiffs' claim and on Defendants' counterclaims, and close this case. Signed by Chief Judge Miranda M. Du on 3/30/2020. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/30/2020) (0) |
| Mar 30, 2020 | 382 | JUDGMENT entered in favor of Defendants pursuant to ECF No. 381 Order. Signed by Clerk of Court Debra K. Kempi on 3/30/2020. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/30/2020) (0) |
| Mar 24, 2020 | 380 | NOTICE of Change of Address by Claire A Fundakowski. (Fundakowski, Claire) (Entered: 03/24/2020) (0) |
| Feb 28, 2020 | 378 | POST TRIAL BRIEF by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. . (Fundakowski, Claire) (Entered: 02/28/2020) (0) |
| Feb 28, 2020 | 379 | POST TRIAL BRIEF by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. . (Hosmer-Henner, Adam) (Entered: 02/28/2020) (0) |
| Feb 27, 2020 | 376 | NOTICE Plaintiffs' Notice of Corrected Filing (ECF No. 374) by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited re 374 Proposed Findings of Fact.. (Hosmer-Henner, Adam) (Entered: 02/27/2020) (0) |
| Feb 27, 2020 | 377 | NOTICE Plaintiffs' Notice of Corrected Filing (ECF No. 374) by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited re 374 Proposed Findings of Fact, 376 Notice (Other).. (Hosmer-Henner, Adam) (Entered: 02/27/2020) (0) |
| Feb 21, 2020 | 375 | NOTICE of Docket Correction to 362 Exhibit List: There was an error in on the image in ECF No. 362 -1. The error has been corrected and the image to 362 -1 has been replaced. (no image attached) (PAV) (Entered: 02/21/2020) (0) |
| Feb 14, 2020 | 372 | NOTICE Plaintiffs' Notice of Lodging Redacted Versions of Trial Exhibits Containing Confidential Proprietary and Trade Secret Information by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Hosmer-Henner, Adam) (Entered: 02/14/2020) (0) |
| Feb 14, 2020 | 373 | PROPOSED Findings of Fact by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc. . (Fundakowski, Claire) (Entered: 02/14/2020) (0) |
| Feb 14, 2020 | 374 | PROPOSED Findings of Fact by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited Plaintiffs' Post-Trial Proposed Findings of Fact and Conclusions of Law. (Hosmer-Henner, Adam) (Entered: 02/14/2020) (0) |
| Feb 5, 2020 | 365 | TRANSCRIPT of Proceedings, 347 Bench Trial,,, held on 1-13-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 5, 2020 | 366 | TRANSCRIPT of Proceedings, 348 Bench Trial,,,, held on 1-14-2020, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 5, 2020 | 367 | TRANSCRIPT of Proceedings, 351 Bench Trial,,, held on 1-15-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 5, 2020 | 368 | TRANSCRIPT of Proceedings, 354 Bench Trial,,, held on 1-17-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 5, 2020 | 369 | TRANSCRIPT of Proceedings, 355 Bench Trial,,,, held on 1-21-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 5, 2020 | 370 | TRANSCRIPT of Proceedings, 356 Bench Trial,,, held on 1-27-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 5, 2020 | 371 | TRANSCRIPT of Proceedings, 358 Bench Trial,,,,,,,, held on 1-28-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/26/2020. Redacted Transcript Deadline is set for 3/7/2020. Release of the Transcript Restriction is set for 5/5/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 02/05/2020) (0) |
| Feb 3, 2020 | 363 | NOTICE of Docket Correction to 358 Bench Trial: The Deadline for the filing of amended proposed findings of fact date is correct on the attached minutes of proceedings and incorrect on the docket entry. The correct date is 2/14/2020. (no image attached) (PAV) (Entered: 02/03/2020) (0) |
| Feb 3, 2020 | 364 | RESPONSE to 359 Notice (Other), 358 Bench Trial,,,,,,,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Allen, W.) (Entered: 02/03/2020) (0) |
| Jan 31, 2020 | 361 | BENCH TRIAL EXHIBIT LIST by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited.. (PAV) (Additional attachment(s) added on 1/31/2020: # 1 Exhibit exhibit list, # 2 Exhibit exhibit list, # 3 Exhibit exhibit list) (PAV). (Entered: 01/31/2020) (0) |
| Jan 31, 2020 | 362 | BENCH TRIAL EXHIBIT LIST by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Attachments: # 1 Exhibit exhibit list)(PAV) (Attachment 1 replaced on 2/21/2020) (PAV). (Attachment 1 replaced on 2/21/2020) (PAV). (Entered: 01/31/2020) (0) |
| Jan 29, 2020 | 358 | MINUTES OF PROCEEDINGS - Bench Trial, day 7, held on 1/28/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael Kennedy, Jeffrey Ellikan, Alaina Whitt, Han Park, Daniel Farnolly, Eric Sonnenschein; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Allison Heydorn (for Hikma);Constance Huttner, Michael Rounds, Caroline Sun (for DRL); Court Reporter: Kathy French; Time of Hearing: 8:32 AM - 2:50 PM; Courtroom: 5. Please see minutes for specifics. Plaintiff's witness: Peter Paul Toth. Exhibits are marked and admitted. Ms. Whitt submits the Deposition designations of Peter Mathers and Howard Weintraub on behalf of Plaintiffs. Ms. Sun submits the deposition designations of Aaron Berg on behalf of Defendants. All sides rest. The Court addresses post-trial deadlines and issues. Mr. Sipes asks to submit additional exhibits in the form of articles regarding the CMS open payments exhibits. The Court will allow Plaintiffs to share the proposed exhibits with Defendants. Defendants will respond to Plaintiffs regarding the proposed exhibits by 1/28/2020. Defendants are directed to file a response to the proposed exhibits by 2/3/2020. Mr. Sipes addresses the Court on Plaintiff's request to redact certain exhibits prior to the exhibits being entered into the Court's exhibit room. The Court directs Plaintiff to submit a list of redactions that includes the exhibit number, relevant page, and a statement that indicates why there is a compelling interest to seal by 2/11/2020. Defendant will have until 2/12/2020 to file a response. Amended proposed findings of fact, conclusions of law are due by 2/14/2020. Counsel are to cite to the transcript to support their proposals. Post-trial briefs of no more than 30 pages are due by 2/28/2020. Counsel are directed to submit Word versions of the amended proposed findings of fact, conclusions of law and the post-trial briefs to the Courtroom Administrator. (Copies have been distributed pursuant to the NEF - PAV) Modified on 2/3/2020 (PAV). (Entered: 01/29/2020) (0) |
| Jan 29, 2020 | 359 | NOTICE Plaintiffs' Submission Pursuant to Minutes of Proceedings on January 28, 2020 (ECF NO. 358) by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Hosmer-Henner, Adam) (Entered: 01/29/2020) (0) |
| Jan 29, 2020 | 360 | EXHIBIT LIST Plaintiffs' Third Supplement to Trial Exhibit List by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Attachments: # 1 Exhibit A)(Hosmer-Henner, Adam) (Entered: 01/29/2020) (0) |
| Jan 28, 2020 | 357 | SUPPLEMENT to 345 Exhibit List, 326 Exhibit List, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A)(Rounds, Michael) (Entered: 01/28/2020) (0) |
| Jan 27, 2020 | 356 | MINUTES OF PROCEEDINGS - Bench Trial, Day 6 held on 1/27/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael Kennedy, Jeffrey Ellikan, Alaina Whitt, Han Park, Daniel Farnoly, Eric Sonnenschein; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Allison Heydorn (for Hikma); Constance Huttner, Michael Rounds, Caroline Sun (for DRL); Court Reporter: Kathy French; Time of Hearing: 8:31 AM - 10:32 AM; 11:21 AM - 1:05 PM; 2:24 PM - 3:38 PM; Courtroom: 5. Please see attached minutes for specifics. Plaintiff's witness: Peter Paul Toth. Exhibits are marked and admitted. Bench Trial is continued to 1/28/2020 at 08:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/27/2020) (0) |
| Jan 22, 2020 | 355 | MINUTES OF PROCEEDINGS - Bench Trial held on 1/21/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael Kennedy, Jeffrey Ellikan, Alaina Whitt, Han Park, Daniel Farnolly, Eric Sonnenschein; Def Counsel: : Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Allison Heydorn (for Hikma); Constance Huttner, Michael Rounds, James Barabas, Caroline Sun (for Defendant DRL); Court Reporter: Kathy French; Time of Hearing: 8:30 AM - 5:24 PM; Courtroom: 5. Please see minutes for specifics. Defendants' witness: Ivan Hofmann. Exhibits are marked and admitted. Defendants rests their case in chief on invalidity, subject to deposition designations, and reserving the right to present rebuttal to Plaintiff's rebuttal. Plaintiff's witnesses: Carl Peck, Sean Nicholson. Exhibits are marked and admitted. Bench Trial is continued to 1/27/2020 at 08:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. Bench Trial set for 1/28/2020 at 08:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/22/2020) (0) |
| Jan 21, 2020 | 354 | MINUTES OF PROCEEDINGS - Bench Trial, day 4, held on 1/17/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael Kennedy, Jeffrey Ellikan, Alaina Whitt, Han Park, Daniel Farnolly, Eric Sonnenschein; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Allison Heydorn (for Hikma); Constance Huttner, Michael Rounds, James Barabas, Caroline Sun (for DRL) ; Court Reporter: Kathy French; Time of Hearing: 8:35 AM - 4:52 PM; Courtroom: 5. Please see minutes for specifics. Defendants' witness: Edward Fisher. Exhibits marked and admitted. Bench trial is continued to 1/21/2020 at 8:30 AM Reno Courtroom 5 before Chief Judge Miranda M. Du. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/21/2020) (0) |
| Jan 17, 2020 | 353 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 1/17/2020. By Deputy Clerk: Peggie Vannozzi. Plaintiffs have notified the Court that they have no objection to the Court unsealing unredacted version of Defendants' trial brief and proposed findings. (ECF No. 350 .) Accordingly, the Clerk of Court is directed to unseal Defendants' trial brief (ECF No. 335 ) and proposed findings (ECF No. 336 ).(no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/17/2020) (0) |
| Jan 16, 2020 | 350 | RESPONSE to 343 Order on Motion to Seal,,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Hosmer-Henner, Adam) (Entered: 01/16/2020) (0) |
| Jan 16, 2020 | 351 | MINUTES OF PROCEEDINGS - Bench Trial held on 1/15/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Allison Heydorn (for Hikma); Constance Huttner, Michael Rounds, James Barabas (for DRL); Court Reporter: Kathy French; Time of Hearing: 8:30 AM - 5:00 PM; Courtroom: 5. Please see minutes for specifics. Defendants' witnesses: Jonathan Scheinberg, Jay Walter Heineke. Exhibits marked and admitted. Bench Trial is continued to 1/17/2020 at 08:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/16/2020) (0) |
| Jan 16, 2020 | 352 | EXHIBIT LIST Second Supplement to Plaintiffs' Trial Exhibit List by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Attachments: # 1 Exhibit A)(Hosmer-Henner, Adam) (Entered: 01/16/2020) (0) |
| Jan 15, 2020 | 348 | MINUTES OF PROCEEDINGS - Bench Trial held on 1/14/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Claire Fundakowski, Alison Heydorn (for Hikma) Constance Huttner, Michael Rounds, James Barabas (for DRL); Court Reporter: Kathy French; Time of Hearing: 8:30 AM - 5:32 PM; Courtroom: 5. Please see attached minutes for specifics. Plaintiff's witness: Matthew Budoff. Exhibits are marked and admitted. Plaintiff closes its case. Ms. Fundakowski makes a Rule 52(c) motion on behalf of Defendants. Mr. Sipes responds. The Court reserves its ruling. Defendants' witness: Jonathan Scheinberg. Exhibits are marked and admitted. The Court advises counsel it will issue an oral ruling on Defendants' Rule 52(c) motion. For the reasons the Court has placed on the record, Defendants' Rule 52(c) motion is denied. Bench Trial is continued to 1/15/2020 at 08:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/15/2020) (0) |
| Jan 15, 2020 | 349 | APPENDIX of DDX Numbers and Corresponding DX Exhibit Numbers Used in the Cross Examination of Steve Ketchum, Ph.D. to 345 Exhibit List, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Fundakowski, Claire) (Entered: 01/15/2020) (0) |
| Jan 14, 2020 | 345 | EXHIBIT LIST by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Attachments: # 1 Exhibit A)(Rounds, Michael) (Entered: 01/14/2020) (0) |
| Jan 14, 2020 | 346 | EXHIBIT LIST Plaintiffs' Supplemental Trial Exhibit List by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Attachments: # 1 Exhibit A)(Hosmer-Henner, Adam) (Entered: 01/14/2020) (0) |
| Jan 14, 2020 | 347 | MINUTES OF PROCEEDINGS - Bench Trial, Day 1, held on 1/13/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Megan Keane, Christopher Sipes, Michael Kennedy, Jeffrey Ellikan, Alaina Whitt, Han Park, Daniel Farnolly, Eric Sonnenschein; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen, Clair Fundakowski, Allison Heydorn (for Hikma); Constance Huttner, Michael Rounds, James Barabas (for DRL); Court Reporter: Kathy French; Time of Hearing: 8:35 AM - 5:20 PM; Courtroom: 5. Please see attached minutes for specifics. Mr. Sipes and Mr. Klein make opening statements. Plaintiff's witness: Steve Ketchum. Exhibits marked and admitted. Bench trial is continued to 1/14/2020 at 8:30 AM. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/14/2020) (0) |
| Jan 13, 2020 | 344 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 1/13/2020. ORDER granting 341 Motion to Remove Attorney from Electronic Service List; Attorney Jennifer Marie Coronel; Myoka Kim Goodin; Nina Vachhani; Justin James Bustos and Alan Clement terminated. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/13/2020) (0) |
| Jan 10, 2020 | 341 | MOTION to remove attorney Alan Clement, Jennifer Marie Coronel, Myoka Kim Goodin, Nina Vachhani and Justin Bustos from the Electronic Service List in this case by Counter Claimant Hikma Pharmaceuticals USA Inc., Defendant Hikma Pharmaceuticals USA Inc.. (Allen, W.) (Entered: 01/10/2020) (0) |
| Jan 10, 2020 | 342 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 1/10/2020. Good cause appearing, the parties' stipulation of facts (ECF No. 324 ) is granted. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/10/2020) (0) |
| Jan 10, 2020 | 343 | ORDERED that Defendants' motion to seal (ECF No. 334 ) is denied. It is further ordered that Plaintiffs must show cause in writing within five days of the date of entry of this order (1/15/2020) why the Court should not unseal the unredacted briefs referenced in Defendants' motion to seal (ECF Nos. 335 , 336 ). If Plaintiffs do not respond within five days, the Court will direct the Clerk of Court to unseal the documents. Signed by Chief Judge Miranda M. Du on 1/10/2020. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/10/2020) (0) |
| Jan 8, 2020 | 339 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 1/8/2020. Before the Court is Defendants response (ECF No. 337) to the Courts prior order giving Defendants five days to indicate whether they objected to the unsealing of certain exhibits (ECF No. 315 at 9-10). Defendants state they have no objection to those exhibits being unsealed. (ECF No. 337 at 2.) The Clerk of Court is therefore directed to unseal those exhibits (ECF Nos. 301, 302, 303, 304). (no image attached) (Copies have been distributed pursuant to the NEF - Houston, Thad) (Entered: 01/08/2020) (0) |
| Jan 8, 2020 | 340 | TRANSCRIPT of Proceedings, 322 Order on Motion in Limine,,,,,,,, Order on Motion to Seal,,,,,,,, Calendar Call,,,,,,, held on 1-06-20, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 1/29/2020. Redacted Transcript Deadline is set for 2/8/2020. Release of the Transcript Restriction is set for 4/7/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 01/08/2020) (0) |
| Jan 7, 2020 | 332 | TRIAL BRIEF by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. . (Fundakowski, Claire) (Entered: 01/07/2020) (0) |
| Jan 7, 2020 | 333 | PROPOSED Findings of Fact by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc. . (Fundakowski, Claire) (Entered: 01/07/2020) (0) |
| Jan 7, 2020 | 334 | MOTION to Seal 333 Proposed Findings of Fact, 332 Brief, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 01/07/2020) (0) |
| Jan 7, 2020 | 335 | SEALED UNREDACTED DOCUMENT to 332 Brief, 334 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Rounds, Michael) Modified on 1/17/2020 to unseal per ECF No. 353 (PAV). (Entered: 01/07/2020) (0) |
| Jan 7, 2020 | 336 | SEALED UNREDACTED DOCUMENT to 333 Proposed Findings of Fact, 334 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Rounds, Michael) Modified on 1/17/2020 to unseal per ECF No. 353 . (PAV). Modified on 1/30/2020 to unseal per ECF No. 353 Order (AB). (Entered: 01/07/2020) (0) |
| Jan 7, 2020 | 337 | RESPONSE to 315 Order on Motion in Limine,,,,,,,, Order on Motion to Seal,,,,,,,,,,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fountain, Jonathan) (Entered: 01/07/2020) (0) |
| Jan 7, 2020 | 338 | ORDER APPROVING ECF no. 323 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Alison M. Heydorn for Hikma Pharmaceuticals USA Inc., and Hikma Pharmaceuticals International Ltd., and approving Designation of Local Counsel W. West Allen. Signed by Chief Judge Miranda M. Du on 1/7/2020. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/08/2020) (0) |
| Jan 6, 2020 | 320 | ORDER APPROVING ECF No. 317 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Jeffrey B. Elikan for Amarin Pharma, Inc., and Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Chief Judge Miranda M. Du on 1/6/2020. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 321 | ORDER APPROVING ECF No. 318 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Daniel J. Farnoly for Amarin Pharma, Inc., and Amarin Pharmaceuticals Ireland Limited,and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Chief Judge Miranda M. Du on 1/6/2020. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 322 | MINUTES OF PROCEEDINGS - Telephonic Calendar Call held on 1/6/2020 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Jason Misth, Chroistopher Sipes, Megan Keane, Alaina Whitt, Adam Hosmer-Henner; Def Counsel: Claire Fundakowski, Eimeric Reig-Plessis, Charles Klein, West Allen (for Defendant Westward/Hickma); Beth Finkelstein, Constance Huttner, Caroline Sun, Michael Rounds, James Barabas (for Defendant DRL); Court Reporter: Kathy French; Time of Hearing: 1:10 PM - 1:25 PM; Courtroom: 5; Also present: Joe Kennedy, General Counsel for Plaintiff. The Court advises counsel that it has reviewed Defendant DRL's motion in limine (ECF No. 310 ), Plaintiff's response (ECF No. 316 ) and the transcript of the 12/17/2019 hearing. The Court has also reviewed DRL's motion to seal (ECF No. 311 .) For the reasons the Court has placed on the record, Defendant DRL's motion to seal (ECF No. 311 ) is granted. Ms. Huttner and Mr. Sipes present argument. For the reasons the Court has placed on the record, Defendant DRL's motion in limine (ECF No. 310 ) is denied. The Court and counsel discuss the trial schedule. The trial will begin at 8:30 AM on 1/13/2020 in Reno Courtroom 5 before Chief Judge Miranda M. Du. The Court inquires as to whether it should be in session on 1/21/2020. Ms. Huttner and Mr. Sipes address the Court. The Court will keep 1/21/2020 open as a trial date. The Court will not require counsel to divide their exhibits into small file sizes. Counsel may submit large files in total without dividing the files into smaller files. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) Modified on 1/6/2020 (PAV). Modified on 1/6/2020 (PAV). (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 323 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Alison M. Heydorn and DESIGNATION of Local Counsel W. West Allen (Filing fee $ 250 receipt number 0978-5834670) by Counter Claimant Hikma Pharmaceuticals USA Inc., Defendant Hikma Pharmaceuticals USA Inc.. (Allen, W.) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 324 | Joint STIPULATION Stipulations of Fact re 213 Order Regarding Trial,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Smith, Jason) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 325 | EXHIBIT LIST List of Admitted Exhibits by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Attachments: # 1 Exhibit A)(Smith, Jason) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 326 | EXHIBIT LIST by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Attachments: # 1 Exhibit A)(Fundakowski, Claire) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 327 | TRIAL BRIEF re 213 Order Regarding Trial,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. . (Smith, Jason) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 328 | WITNESS LIST by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Fundakowski, Claire) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 329 | WITNESS LIST Plaintiffs' Witness List by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Smith, Jason) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 330 | EXHIBIT LIST Plaintiffs' Exhibit List by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. (Attachments: # 1 Exhibit A)(Smith, Jason) (Entered: 01/06/2020) (0) |
| Jan 6, 2020 | 331 | PROPOSED Findings of Fact by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited . (Smith, Jason) (Entered: 01/06/2020) (0) |
| Jan 3, 2020 | 317 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Jeffrey B. Elikan and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-5832352) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 01/03/2020) (0) |
| Jan 3, 2020 | 318 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Daniel J. Farnoly and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-5832390) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 01/03/2020) (0) |
| Jan 3, 2020 | 319 | NOTICE of Appearance by attorney Adam Hosmer-Henner on behalf of Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Hosmer-Henner, Adam) (Entered: 01/03/2020) (0) |
| Jan 2, 2020 | 315 | ORDERED that Defendants' consolidated motion in limine (ECF No. 291 ) is granted in part, and denied in part, as specified herein. Plaintiffs' consolidated motion in limine (ECF No. 292 ) is denied except to the extent it seeks to bar the testimony of Mr. Kunin and Mr. Godici. Defendants' motion to seal (ECF No. 297 ) is granted. Plaintiffs' motion to seal (ECF No. 300 ) is denied. Defendants must show cause in writing within five days (1/7/2020) why the Court should not unseal the exhibits referenced in Plaintiffs' motion to seal (ECF Nos. 301 , 302 , 303 , 304 ). If Defendants do not respond within five days, the Court will direct the Clerk of Court to unseal the documents. Signed by Chief Judge Miranda M. Du on 1/2/2020. (Copies have been distributed pursuant to the NEF - DRM) Modified on 1/2/2020 for punctuation (DRM). (Entered: 01/02/2020) (0) |
| Jan 2, 2020 | 316 | RESPONSE to 310 Motion in Limine,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 1/9/2020. (Attachments: # 1 Declaration of Michael Kennedy, Esq., # 2 Index of Exhibits, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Certificate of Service) (Smith, Jason) (Entered: 01/02/2020) (0) |
| Dec 27, 2019 | 314 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 12/27/2019. The Court has reviewed the parties joint status report (ECF No. 313), and agrees as to both recommendations contained within the status report. Therefore, trial will be held in Reno, and the parties may submit their exhibits as outlined in the joint status report. (no image attached) (Copies have been distributed pursuant to the NEF - Houston, Thad) (Entered: 12/27/2019) (0) |
| Dec 26, 2019 | 310 | MOTION in Limine by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... Responses due by 1/9/2020. (Attachments: # 1 Declaration Beth Finkelstein, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16)(Finkelstein, Beth) (Entered: 12/26/2019) (0) |
| Dec 26, 2019 | 311 | MOTION to Seal 310 Motion in Limine,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... (Finkelstein, Beth) (Entered: 12/26/2019) (0) |
| Dec 26, 2019 | 313 | Joint STATUS REPORT Joint Status Report Pursuant to the Court's December 17, 2019 Order (ECF No. 307) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 12/26/2019) (0) |
| Dec 23, 2019 | 309 | AMENDED MINUTES OF PROCEEDINGS: MINUTES OF PROCEEDINGS - Pretrial Conference held on 12/17/2019 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Christopher Sipes, Michael Kennedy, Alaina Whitt, Jordan Smith; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen (for Westward), Constance Huttner, Michal Rounds, Caroline Sun (for DRL); Court Reporter: Kathy French; Time of Hearing: 9:30 AM - 10:10 AM; Courtroom: 5. The Court advises counsel that there are a couple of issues to discuss. The Court expresses its preference that the bench trial be held in Reno instead of Las Vegas. Mr. Sipes, Mr. Klein and Ms. Huttner respond. The Court sets the following schedule for the trial: Week 1: January 13 through 15, and January 17, 2020. January 16 will be a dark day. Week 2: January 21, 2020 only. The remainder of the week will be dark. Week 3: January 27 through 31, 2020. The Joint Pretrial Order mentions the reading of deposition designations and playing video depositions. The Court will only hear live testimony and will review the deposition designations and video depositions outside of the trial itself. The parties will have 30 minutes each to present opening statements. No closing statements will be allowed. Counsel will be allowed to file post-trial briefs on an expedited basis. The Court directs counsel to meet and confer and file a joint status report that indicates whether the trial should be held in Reno or Las Vegas. The status report is due by 12/26/2019. Ms. Huttman asks the Court to resolve a dispute regarding the timing for exchanges of exhibits and demonstrative aids. Plaintiff is asking for 2 day advance note. Defendants wish to give 1 day notice. The Court directs counsel to provide 2 day notice for the first week. The issue can be revisited as necessary. Ms. Huttner advises the Court that Plaintiffs delivered some of the documents requested by Defendants' motion to compel (ECF No. 268 ) on Friday, 12/13/2019. She asks for leave of the Court for Defendants to file an additional motion in limine. Mr. Sipes responds. The Court denies Defendants' motion to compel (ECF No. 268 ) as moot. The Court grants leave to file a late motion in limine of no more that 10 pages per side. The motion in limine is due 12/26/2019. Responses of no more than 10 pages are due 1/2/2020. Plaintiff agrees to provide documents relating to the FDA communications by 12/23/2019. The Court directs the parties to confer on the motions in limine prior to filing. The Court will try to resolve pending motions in limine by 12/27/2019. The telephonic calendar call remains set for 1/6/2020 at 1:00 PM in Reno Courtroom 5 before Chief Judge Miranda M. Du. Counsel are to call 1-888-251-2909, at least 5 minutes prior to the hearing, and enter code 3803398 and passcode 010620. The use of cell phones and/or speaker phones is prohibited. Please note: amendments are in bold. The Court will not be in session on 1/16/2020. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 12/23/2019) (0) |
| Dec 18, 2019 | 308 | TRANSCRIPT of Proceedings, 307 Order on Motion to Compel,,,,,,,,,,,,, Pretrial Conference,,,,,,,,,,,, held on 12-17-19, before Chief Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 1/8/2020. Redacted Transcript Deadline is set for 1/18/2020. Release of the Transcript Restriction is set for 3/17/2020. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 12/18/2019) (0) |
| Dec 17, 2019 | 307 | MINUTES OF PROCEEDINGS - Pretrial Conference held on 12/17/2019 before Chief Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Christopher Sipes, Michael Kennedy, Alaina Whitt, Jordan Smith; Def Counsel: Charles Klein, Eimeric Reig-Plessis, W. West Allen (for Westward), Constance Huttner, Michal Rounds, Caroline Sun (for DRL); Court Reporter: Kathy French; Time of Hearing: 9:30 AM - 10:10 AM; Courtroom: 5. The Court advises counsel that there are a couple of issues to discuss. The Court expresses its preference that the bench trial be held in Reno instead of Las Vegas. Mr. Sipes, Mr. Klein and Ms. Huttner respond. The Court sets the following schedule for the trial: Week 1: January 13 through 15, 2020. January 16 and 17 will be dark days. Week 2: January 21, 2020 only. The remainder of the week will be dark. Week 3: January 27 through 31, 2020. The Joint Pretrial Order mentions the reading of deposition designations and playing video depositions. The Court will only hear live testimony and will review the deposition designations and video depositions outside of the trial itself. The parties will have 30 minutes each to present opening statements. No closing statements will be allowed. Counsel will be allowed to file post-trial briefs on an expedited basis. The Court directs counsel to meet and confer and file a joint status report that indicates whether the trial should be held in Reno or Las Vegas. The status report is due by 12/26/2019. Ms. Huttman asks the Court to resolve a dispute regarding the timing for exchanges of exhibits and demonstrative aids. Plaintiff is asking for 2 day advance note. Defendants wish to give 1 day notice. The Court directs counsel to provide 2 day notice for the first week. The issue can be revisited as necessary. Ms. Huttner advises the Court that Plaintiffs delivered some of the documents requested by Defendants' motion to compel (ECF No. 268 ) on Friday, 12/13/2019. She asks for leave of the Court for Defendants to file an additional motion in limine. Mr. Sipes responds. The Court denies Defendants' motion to compel (ECF No. 268 ) as moot. The Court grants leave to file a late motion in limine of no more that 10 pages per side. The motion in limine is due 12/26/2019. Responses of no more than 10 pages are due 1/2/2020. Plaintiff agrees to provide documents relating to the FDA communications by 12/23/2019. The Court directs the parties to confer on the motions in limine prior to filing. The Court will try to resolve pending motions in limine by 12/27/2019. The telephonic calendar call remains set for 1/6/2020 at 1:00 PM in Reno Courtroom 5 before Chief Judge Miranda M. Du. Counsel are to call 1-888-251-2909, at least 5 minutes prior to the hearing, and enter code 3803398 and passcode 010620. The use of cell phones and/or speaker phones is prohibited. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 12/17/2019) (0) |
| Dec 16, 2019 | 305 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 12/16/2019. By Deputy Clerk: Peggie Vannozzi. The Pretrial Conference set for 12/17/2020 at 10:00 AM is advanced to 9:30 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 12/16/2019) (0) |
| Dec 16, 2019 | 306 | MINUTES OF PROCEEDINGS - Settlement Conference held on 12/16/2019 before Magistrate Judge Nancy J. Koppe. Pla Counsel: Jason Smith, Christopher Sipes, Mike Kennedy, Alaina Whitt; Pla rep Joe Kennedy present; Defs Counsel: Constance Huffner, Carolyn Sun, Frank Rodriguez, Chuck Klein, W. West Allen; Defs reps Andrew Allen and Neema Kuma present; Time of Hearing: 9:00 a.m. - 11:17 a.m. The Court, the parties, and counsel conferred, but no settlement was reached. This case returns to the normal litigation track. (no image attached) (Copies have been distributed pursuant to the NEF - JH) (Entered: 12/16/2019) (0) |
| Dec 13, 2019 | 296 | RESPONSE to 292 Motion in Limine, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. Replies due by 12/20/2019. (Attachments: # 1 Declaration Claire A. Fundakowski, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18) (Fundakowski, Claire) (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 297 | MOTION to Seal 296 Response,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 299 | RESPONSE to 291 Motion in Limine, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 12/20/2019. (Attachments: # 1 Declaration of Jordan L. Moran, # 2 Index of Exhibits, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Certificate of Service) (Smith, Jason) (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 300 | MOTION to Seal 299 Response, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 301 | EXHIBIT 1 to 299 Response, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 1/8/2020 to unseal per ECF No. 339 Minute Order (LH). (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 302 | EXHIBIT 2 to 299 Response, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 1/8/2020 to unseal per ECF No. 339 Minute Order (LH). (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 303 | EXHIBIT 3 to 299 Response, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 1/8/2020 to unseal per ECF No. 339 Minute Order(LH). (Entered: 12/13/2019) (0) |
| Dec 13, 2019 | 304 | EXHIBIT 4 to 299 Response, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 1/8/2020 to unseal per ECF No. 339 Minute Order(LH). (Entered: 12/13/2019) (0) |
| Dec 10, 2019 | 295 | PRETRIAL ORDER. Status Conference set for 12/17/2019 at 10:00 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. Telephonic Calendar Call is set for 1/6/2020 at 01:00 PM in Reno Courtroom 5 before Chief Judge Miranda M. Du. Counsel are to call 1-888-251-2909, at least 5 minutes prior to the hearing, and enter code 3803398 and passcode 010620. Please note corrected passcode. The use of speaker phones and/or cell phones is prohibited. Bench Trial set for 1/13/2020 at 09:00 AM in a Las Vegas Courtroom to be determined before Chief Judge Miranda M. Du. Signed by Chief Judge Miranda M. Du on 12/10/2019. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 12/10/2019) (0) |
| Dec 6, 2019 | 294 | Proposed Joint Pretrial Order by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Index of Exhibits, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D) (Smith, Jason) (Entered: 12/06/2019) (0) |
| Nov 27, 2019 | 291 | MOTION in Limine by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc... Responses due by 12/11/2019. (Attachments: # 1 Declaration Claire A. Fundakowski, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4)(Fundakowski, Claire) (Entered: 11/27/2019) (0) |
| Nov 27, 2019 | 292 | MOTION in Limine by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.. Responses due by 12/11/2019. (Attachments: # 1 Declaration of Jordan L. Moran, # 2 Appendix, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Certificate of Service)(Whitt, Alaina) (Entered: 11/27/2019) (0) |
| Nov 27, 2019 | 293 | ORDER re ECF No. 283 Brief, ECF No. 290 Response, requiring no further action as to the exhibits and their corresponding motions to seal. Signed by Chief Judge Miranda M. Du on 11/27/2019. (Copies have been distributed pursuant to the NEF - KR) (Entered: 12/02/2019) (0) |
| Nov 18, 2019 | 290 | RESPONSE to 283 Brief,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit 12 (redacted), # 2 Exhibit 13, # 3 Exhibit 16) (Smith, Jason) (Entered: 11/18/2019) (0) |
| Nov 15, 2019 | 289 | ORDER - The Court GRANTS the parties' request based on the parties' noted assurances. (ECF No. 287 .) All other requirements outlined in the Court's order at ECF No. 284 remain in effect. (See pdf order for specifics.) Signed by Magistrate Judge Nancy J. Koppe on 11/15/2019.(Copies have been distributed pursuant to the NEF - DRM) (Entered: 11/15/2019) (0) |
| Nov 14, 2019 | 287 | UNOPPOSED MOTION NOTICE Joint Request for Exception to Settlement Conference Attendance Requirement by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. re 284 Order Setting Settlement Conference,,,,,. (Attachments: # 1 Proposed Order) (Sun, Caroline) Modified on 11/14/2019 changed notice to motion(LE). (Entered: 11/14/2019) (0) |
| Nov 14, 2019 | 288 | NOTICE of Docket Correction to 287 Unopposed Motion for Exception to Settlement Conference Attendance Requirement: QC changed entry from a notice to a motion. Filer is advised when requesting an action from the Court to file a motion. (no image attached) (LE) (Entered: 11/14/2019) (0) |
| Nov 12, 2019 | 286 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 11/12/2019. By Deputy Clerk: Peggie Vannozzi. Pretrial Conference is set for 12/17/2019 at 10:00 AM in Reno Courtroom 5 before Chief Judge Miranda M. Du. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 11/12/2019) (0) |
| Nov 8, 2019 | 285 | NOTICE Notice of Intent to File a Reponse to ECF No. 283 by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited re 283 Brief,,. (Smith, Jason) (Entered: 11/08/2019) (0) |
| Nov 7, 2019 | 282 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 11/7/2019. Good cause appearing, the stipulations (ECF Nos. 280 and 281 ) to extend time to file pretrial order, set pretrial settlement conference date, set pretrial status conference date, and set other pretrial deadlines are granted in part and denied in part. The stipulations are granted as to extending the date to file the joint pretrial order to 12/6/2019 and as the request to approve the proposed schedule as the deadlines relate to the parties' obligations and reaffirmation of the deadlines in the Order Regarding Bench Trial (ECF No. 213 ); the Court will try to accommodate the parties' request to set a status conference for the week of December 16, 2019; however, whether the settlement conference will be set for the week of December 16, 2019 is a matter for Magistrate Judge Koppe to decide based on her schedule and this request will be referred to Judge Koppe. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 11/07/2019) (0) |
| Nov 7, 2019 | 283 | SUPPLEMENTAL BRIEF re 278 Order on Motion for Partial Summary Judgment,,,,, Order on Motion to Seal,,,,, Order on Motion for Summary Judgment,,,,,,,,,,,,,,,,,,,,,,,,,,,,, 235 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit 14, # 2 Exhibit 15) (Sun, Caroline) (Entered: 11/07/2019) (0) |
| Nov 7, 2019 | 284 | ORDER Scheduling a Settlement Conference for 12/16/2019 at 9:00 AM in the third floor LV Chambers of Magistrate Judge Nancy J. Koppe. The settlement conference statements shall be submitted, in an envelope marked "Confidential," directly to the undersigned's box in the Clerk's Office not later than 3:00 PM on 12/6/2019. DO NOT SERVE A COPY ON OPPOSING COUNSEL. Signed by Magistrate Judge Nancy J. Koppe on 11/7/2019. (Copies have been distributed pursuant to the NEF - LH) (Entered: 11/07/2019) (0) |
| Nov 6, 2019 | 280 | STIPULATION FOR EXTENSION OF TIME (First Request) re Discovery Stipulation to Extend Time to File Pretrial Order (First Request) and Set Pretrial Settlement Conference Date re 180 Order on Motion to Extend/Shorten Time,,,,,,,,,,,,,,,, Motion Hearing,,,,,,, 93 Order, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 11/06/2019) (0) |
| Nov 6, 2019 | 281 | STIPULATION Stipulation to Set Pretrial Status Conference Date and Set Other Pretrial Deadlines re 213 Order Regarding Trial,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 11/06/2019) (0) |
| Oct 29, 2019 | 279 | (1st Notice) Pursuant to Local Rule IC 2-1: that James Barabas is in violation of Local Rule IC 2-1. Participation in the electronic filing system became mandatory for all attorneys effective January 1, 2006. You are required to register to file documents electronically in the Court's electronic filing system (CM/ECF) and the electronic service of pleadings and other papers. Please visit the Court's website to complete the registration for CM/ECF. (no image attached) (DRM) (Entered: 10/29/2019) (0) |
| Oct 28, 2019 | 277 | ORDER granting ECF No. 275 Motion to Substitute Attorney W. West Allen in place of Wayne A. Shaffer for Hikma Pharmaceuticals USA Inc and Hikma Pharmaceuticals International Limited. Signed by Magistrate Judge Nancy J. Koppe on 10/28/2019. (Copies have been distributed pursuant to the NEF - KR) (Entered: 10/29/2019) (0) |
| Oct 28, 2019 | 278 | ORDER Defendants' motion for summary judgment (ECF No. 236 ) as to noninfringement is granted in part, and denied in part, as specified herein. Plaintiff's motion for partial summary judgment (ECF No. 234 ) granted in part, and denied in part as moot, as specified herein. Defendants' Motion to Seal (ECF No. 235 ) is granted in part, and denied in part as specified herein. Defendants must file a supplemental brief or not more than five pages within 10 days of the date of entry of this order providing additional argument as specified herein. Plaintiffs will have 10 days to file a response to Defendants supplemental brief, though none is required. No reply will be permitted. Defendants' Motion to Seal (ECF No. 246 ) is granted. Plaintiffs' Motion to Seal (ECF No. 254 ) is granted. Defendants' Motion to Seal (ECF No. 261 ) is granted. Plaintiffs' Motion to Seal (ECF No. 265 ) is granted. Signed by Chief Judge Miranda M. Du on 10/28/2019. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 10/29/2019) (0) |
| Oct 25, 2019 | 275 | MOTION to Substitute Attorney W. West Allen in for Attorney Wayne A. Shaffer by Counter Claimant Hikma Pharmaceuticals USA Inc., Defendant Hikma Pharmaceuticals USA Inc.. (Allen, W.) (Entered: 10/25/2019) (0) |
| Oct 25, 2019 | 276 | REPLY to Response to 268 Motion to Compel,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Sun, Caroline) (Entered: 10/25/2019) (0) |
| Oct 22, 2019 | 274 | MINUTE ORDER IN CHAMBERS of the Honorable Chief Judge Miranda M. Du on 10/22/2019. Good cause appearing, Defendants motion for leave to file supplemental authority (ECF No. 273) is granted. (no image attached) (Copies have been distributed pursuant to the NEF - Houston, Thad) (Entered: 10/22/2019) (0) |
| Oct 18, 2019 | 272 | RESPONSE to 268 Motion to Compel,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 10/25/2019. (Attachments: # 1 Declaration of Alaina M. Whitt, # 2 Index of Exhibits, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Certificate of Service) (Smith, Jason) (Entered: 10/18/2019) (0) |
| Oct 18, 2019 | 273 | MOTION for Leave to File Supplemental Authority re: 262 REPLY to Response to 236 Motion for Summary Judgment, filed by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit 1) (Fundakowski, Claire) (Entered: 10/18/2019) (0) |
| Oct 7, 2019 | 271 | ORDER granting ECF No. 267 Motion for leave to file the motion to compel under seal; the Clerk is instructed to keep ECF No. 269 under seal. Signed by Magistrate Judge Nancy J. Koppe on 10/7/2019. (Copies have been distributed pursuant to the NEF - LH) (Entered: 10/08/2019) (0) |
| Oct 4, 2019 | 267 | MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Sun, Caroline) (Entered: 10/04/2019) (0) |
| Oct 4, 2019 | 268 | MOTION to Compel re 267 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. Responses due by 10/18/2019. (Attachments: # 1 Declaration Caroline Sun, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15) (Sun, Caroline) (Entered: 10/04/2019) (0) |
| Oct 4, 2019 | 270 | NOTICE of Corrected Image/Document re 267 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Service of corrected image is attached.) (Sun, Caroline) (Entered: 10/04/2019) (0) |
| Sep 13, 2019 | 261 | MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 09/13/2019) (0) |
| Sep 13, 2019 | 262 | REPLY to Response to 236 Motion for Summary Judgment, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Attachments: # 1 Declaration Claire A. Fundakowski, # 2 Exhibit 17, # 3 Exhibit 18) (Fundakowski, Claire) (Entered: 09/13/2019) (0) |
| Sep 13, 2019 | 264 | REPLY to Response to 234 Motion for Partial Summary Judgment, by Plaintiff Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Declaration Reply Declaration of Michael N. Kennedy in Support of Amarin's Motion for Partial Summary Judgment, # 2 Index Index of Exhibits, # 3 Exhibit Ex A - Heinecke Tr Excerpts, # 4 Exhibit Ex B - Toth Tr Excerpts, # 5 Exhibit Ex C - Osterloh Tr Excerpts (FUS), # 6 Exhibit Ex D - Bays Declaration May 18 2011 (727 PFH), # 7 Certificate of Service Certificate of Service) (Smith, Jason) (Entered: 09/13/2019) (0) |
| Sep 13, 2019 | 265 | MOTION to Seal 264 Reply,, by Plaintiff Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 09/13/2019) (0) |
| Aug 30, 2019 | 246 | MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 247 | RESPONSE to 234 Motion for Partial Summary Judgment, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. Replies due by 9/13/2019. (Attachments: # 1 Declaration Claire A. Fundakowski) (Fundakowski, Claire) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 248 | APPENDIX Part 1 to ECF No. 247 to 246 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 249 | APPENDIX Part 2 to ECF No. 247 to 246 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 250 | APPENDIX Part 3 to ECF No. 247 to 246 Motion to Seal, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 252 | RESPONSE to 236 Motion for Summary Judgment, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 9/13/2019. (Smith, Jason) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 253 | APPENDIX of Exhibits to 252 Response by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Appendix A, # 16 Appendix B, # 17 Certificate of Service) (Smith, Jason) (Entered: 08/30/2019) (0) |
| Aug 30, 2019 | 254 | MOTION to Seal by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 08/30/2019) (0) |
| Aug 9, 2019 | 234 | MOTION for Partial Summary Judgment by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 8/30/2019. (Attachments: # 1 Declaration of Michael Kennedy, # 2 Index of Exhibits, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Certificate of Service) (Smith, Jason) (Entered: 08/09/2019) (0) |
| Aug 9, 2019 | 235 | MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/09/2019) (0) |
| Aug 9, 2019 | 236 | MOTION for Summary Judgment by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. Responses due by 8/30/2019. (Fundakowski, Claire) (Entered: 08/09/2019) (0) |
| Aug 9, 2019 | 237 | DECLARATION of Claire A. Fundakowski re 236 Motion for Summary Judgment, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/09/2019) (0) |
| Aug 9, 2019 | 238 | APPENDIX Volume 1 to 236 Motion for Summary Judgment, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/09/2019) (0) |
| Aug 9, 2019 | 239 | APPENDIX Volume 2 to 236 Motion for Summary Judgment, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Hikma Pharmaceuticals USA Inc.. (Fundakowski, Claire) (Entered: 08/09/2019) (0) |
| Aug 7, 2019 | 233 | ORDER granting ECF No. 232 Stipulation re Expert Discovery Deadline. Signed by Magistrate Judge Nancy J. Koppe on 8/7/2019.(Copies have been distributed pursuant to the NEF - LH) (Entered: 08/08/2019) (0) |
| Aug 6, 2019 | 232 | Joint STIPULATION FOR EXTENSION OF TIME (Third Request) re Discovery Joint Stipulation for Extension of Time for Expert Discovery Deadline re 229 Order on Stipulation by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 08/06/2019) (0) |
| Jul 1, 2019 | 231 | ORDER granting ECF No. 230 Verified Petition for Permission to Practice Pro Hac Vice by Attorney James Barabas for Dr. Reddy's Laboratories Inc and Dr. Reddy's Laboratories Ltd, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 7/1/2019. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 07/01/2019) (0) |
| Jun 28, 2019 | 230 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by James Barabas and DESIGNATION of Local Counsel Michael D. Rounds (Filing fee $ 250 receipt number 0978-5606540) by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 06/28/2019) (0) |
| Jun 21, 2019 | 229 | ORDER granting ECF No. 228 Stipulation re Expert Discovery and Claim Reduction Deadline. Signed by Magistrate Judge Nancy J. Koppe on 6/21/2019.(Copies have been distributed pursuant to the NEF - DRM) (Entered: 06/21/2019) (0) |
| Jun 19, 2019 | 228 | Joint STIPULATION FOR EXTENSION OF TIME (Second Request) re Discovery re 146 Order on Stipulation,, Scheduling Order, 203 Status Conference,,,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 06/19/2019) (0) |
| May 15, 2019 | 226 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 5/15/2019. The Court has reviewed Amarin's notice of voluntary withdrawal (ECF No. 225 ). Amarin's filings found at ECF Nos. 218 , 220 and 222 are deemed withdrawn. Amarin's motions to seal (ECF Nos. 219 , 221 , 223 ) are granted. Defendants/Counterclaimants' motion to seal hearing transcript (ECF No. 215 ) is granted. The transcript of the April 17, 2019 hearing (ECF No. 204 ) will remain sealed. The Court Reporter is directed to redact the hearing transcript to reflect the redactions in the sealed document filed at ECF No. 215 -1. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 05/15/2019) (0) |
| May 15, 2019 | 227 | TRANSCRIPT of Proceedings, 203 Status Conference,,,,,, held on 4-17-19, before Judge Miranda M. Du. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 6/5/2019. Redacted Transcript Deadline is set for 6/15/2019. Release of the Transcript Restriction is set for 8/13/2019. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 05/15/2019) (0) |
| May 14, 2019 | 225 | NOTICE Amarin's Notice of Voluntary Withdrawal of Combined Motion to Clarify Order, or in the Alternative, to Unseal or Reconsider Sealing of Joint Status Report, and Opposition to Motion to Seal Transcript (ECF No. 218, 220, 222) by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 05/14/2019) (0) |
| May 8, 2019 | 224 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 5/8/2019. In light of the multiple pending motions relating to the Courts minute order (ECF No. 211) granting the joint motion to seal (Pending Motions) (ECF Nos. 215, 218, 219, 220, 221, 223), the issues covered by that minute order will remain under seal, and must be treated by the parties as sealed, pending the Courts consideration of the Pending Motions. In addition, the full transcript of the April 17, 2019 status conference (ECF No. 204) will be sealed pending the Courts decision on the Pending Motions. (no image attached) (Copies have been distributed pursuant to the NEF - Houston, Thad) (Entered: 05/08/2019) (0) |
| May 6, 2019 | 217 | NOTICE Notice of Intent to File Written Opposition to Defendants' Motion to Seal Transcript (ECF No. 215) by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited re 215 Motion to Seal,. (Smith, Jason) (Entered: 05/06/2019) (0) |
| May 6, 2019 | 219 | MOTION to Seal by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 5/7/2019 to add link to motion 218 (LE). (Entered: 05/06/2019) (0) |
| May 6, 2019 | 221 | MOTION to Seal by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 5/7/2019 add link to related document 220 (LE). (Entered: 05/06/2019) (0) |
| May 6, 2019 | 223 | MOTION to Seal by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) Modified on 5/7/2019 added link to related document 222 (LE). (Entered: 05/06/2019) (0) |
| May 3, 2019 | 215 | MOTION to Seal 204 Transcript,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Exhibit 1) (Rounds, Michael) (Entered: 05/03/2019) (0) |
| Apr 29, 2019 | 214 | CLERK'S SECOND NOTICE Regarding Local Rule IC 2-1(g). Filer's account information is different from the address information contained in the filed document, ECF No. 198 , 200 . Attorney Frank D. Rodriguez is advised to review and update his/her user account information. (no image attached) (WJ) Modified on 5/8/2019 COMPLIED (WJ). (Entered: 04/29/2019) (0) |
| Apr 26, 2019 | 210 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 4/26/2019. Good cause appearing, the parties' motion to seal (ECF No. 207 ) is granted. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/26/2019) (0) |
| Apr 26, 2019 | 211 | AMENDED MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 4/26/2019. By Deputy Clerk: Peggie Vannozzi. The Court agrees with the parties they have shown good cause to grant Defendants Hikma Pharmaceuticals USA, Inc. and Hikma Pharmaceuticals International Limited (collectively, Hikma) and Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s (collectively, DRL) joint motion to seal the redacted version of the joint status report because it contains confidential business information. See LR IA 10-5. It is therefore ordered that Hikma and DRL's joint motion to seal (ECF No. 207 ) is granted. The unredacted version of the joint status report (ECF No. 209 ) will remain sealed. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/26/2019) (0) |
| Apr 26, 2019 | 212 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 4/26/2019. By Deputy Clerk: Peggie Vannozzi. The Court has reviewed the redacted status report (ECF No. 208 ) and the Sealed Status Report (ECF No. 209 .) The parties have confirmed that the January 13, 2020 trial date and January 6, 2020 calendar call date is a viable date. The Court will issue an order regarding trial setting additional deadlines. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/26/2019) (0) |
| Apr 26, 2019 | 213 | ORDER REGARDING TRIAL. Motions in limine must be fully briefed and submitted for decision no later than thirty (30) days before trial. Motions filed after this established deadline will be automatically denied. Counsel are required to meet and confer on the issues raised in the motion in limine before filing the motion and must include a statement certifying compliance with this personal consultation requirement. Telephonic Calendar Call is set for 1/6/2020 at 01:00 PM in Reno Courtroom 5 before Judge Miranda M. Du. Counsel are to call 1-888-251-2909, at least 5 minutes before the hearing, and enter code 3803398 and password 123456. The use of cell phones and/or speaker phones is prohibited. Trial related documents (exhibit lists, proposed findings of fact and conclusions of law, and trial briefs) are due one week before trial. Please see order and the attachment for instructions on the submission of trial related documents. Bench Trial is set for 1/13/2020 at 9:00 AM in Courtroom to be determined. before Judge Miranda M. Du. Signed by Judge Miranda M. Du on 4/26/2019. (Attachments: # 1 Exhibit 1 - JERS memo)(Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/26/2019) (0) |
| Apr 25, 2019 | 206 | ORDER granting ECF No. 205 Motion to Extend Time: Joint Status Report due by 4/25/2019. Signed by Judge Miranda M. Du on 4/25/2019. (Copies have been distributed pursuant to the NEF - KR) (Entered: 04/25/2019) (0) |
| Apr 25, 2019 | 207 | MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 04/25/2019) (0) |
| Apr 25, 2019 | 208 | STATUS REPORT by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 04/25/2019) (0) |
| Apr 24, 2019 | 205 | Joint MOTION to Extend Time (First Request) Joint Motion for One-Day Extension of Deadline to Submit Joint Status Report re 203 Status Conference,,,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 04/24/2019) (0) |
| Apr 17, 2019 | 203 | MINUTES OF PROCEEDINGS - Telephonic Status Conference held on 4/17/2019 before Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Jason Smith, Einar Stole, Christopher Sipes, Alaina Whitt; Def Counsel: Eimeric Reig-Plessis, Wayne Shaffer, Charles Klein (for West-Ward/Hikma) Constance Huttner, Caroline Sun, Michael Rounds (for DRL); Court Reporter: Kathy French; Time of Hearing: 1:37 PM - 2:05 PM; Courtroom: 5. Mr. Sipes, Ms. Huttner and Mr. Klein address the Court and answer questions posed by the Court. The Court sets the bench trial for 1/13/2020 at 9:00 AM in a Las Vegas Courtroom to be determined before Judge Miranda M. Du. A telephonic calendar call is set for 1/6/2020 at 1:00 PM in Reno Courtroom 5 before Judge Miranda M. Du. Mr. Klein is to check with his clients to see whether they will agree to stay the rollout of the product pending this Court's rulings. The Court directs the parties to file a joint status report within 7 days to indicate whether the Court should advance the trial from January 13, 2020 to the Court's first trial stack in December, 2019. Ms. Huttner asks that the Court set a date by which Plaintiff is to notify the parties which claims they will drop. The Court directs Plaintiff to notify the parties no later than 7/10/2019 whether they will drop any claims and which claims they are dropping. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/17/2019) (0) |
| Apr 16, 2019 | 199 | CLERK'S NOTICE Regarding Local Rule IC 2-1(g). Filer's account information is different from the address information contained in the filed document, ECF No. 198 . Attorney Constance S. Huttner is advised to review and update his/her user account information. (no image attached) (WJ) Modified on 4/29/2019 COMPLIED (WJ). (Entered: 04/16/2019) (0) |
| Apr 16, 2019 | 200 | CLERK'S NOTICE Regarding Local Rule IC 2-1(g). Filer's account information is different from the address information contained in the filed document, ECF No. 198 . Attorney Frank D. Rodriguez is advised to review and update his/her user account information. (no image attached) (WJ) Modified on 5/8/2019 COMPLIED (WJ). (Entered: 04/16/2019) (0) |
| Apr 16, 2019 | 201 | CLERK'S NOTICE Regarding Local Rule IC 2-1(g). Filer's account information is different from the address information contained in the filed document, ECF No. 198 . Attorney Caroline Sun is advised to review and update his/her user account information. (no image attached) (WJ) Modified on 4/29/2019 COMPLIED (WJ). (Entered: 04/16/2019) (0) |
| Apr 16, 2019 | 202 | CLERK'S NOTICE Regarding Local Rule IC 2-1(g). Filer's account information is different from the address information contained in the filed document, ECF No. 198 . Attorney Beth Finkelstein is advised to review and update his/her user account information. (no image attached) (WJ) Modified on 4/29/2019 COMPLIED (WJ). (Entered: 04/16/2019) (0) |
| Apr 15, 2019 | 198 | NOTICE of Change of Firm by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 04/15/2019) (0) |
| Apr 11, 2019 | 197 | Joint STATUS REPORT by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 04/11/2019) (0) |
| Apr 10, 2019 | 196 | ORDER granting ECF No. 195 Joint Motion to Extend Time: Joint Status Report due by 4/11/2019. Signed by Judge Miranda M. Du on 4/10/2019. (Copies have been distributed pursuant to the NEF - LH) (Entered: 04/11/2019) (0) |
| Apr 9, 2019 | 195 | Joint MOTION to Extend Time (First Request) Joint Motion for Two-Day Extension of Deadline to Submit Joint Status Report re 194 Order on Motion,,,, Minute Order,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 04/09/2019) (0) |
| Apr 2, 2019 | 194 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 4/2/2019. Good cause appearing, the joint motion for status conference (ECF No. 193 ) is granted. A telephonic status hearing is set for 4/17/2019 at 01:30 PM in Reno Courtroom 5 before Judge Miranda M. Du. This is a tentative setting. Counsel are to call 1-888-251-2909, at least 5 minutes prior to the hearing, and enter code 3803398 and password 123456. The use of speaker phones and/or cell phones is prohibited. Counsel are directed to file a joint status report within 7 days that proposes 3 potential dates for trial and provides an estimate of the number of days this case may take to try. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/02/2019) (0) |
| Apr 1, 2019 | 193 | Joint MOTION by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 4/15/2019. (Attachments: # 1 Exhibit A, # 2 Certificate of Service) (Smith, Jason) (Entered: 04/01/2019) (0) |
| Mar 11, 2019 | 189 | ORDER granting ECF No. 186 Joint Motion to Seal. Signed by Judge Miranda M. Du on 3/11/2019.(Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/11/2019) (0) |
| Mar 11, 2019 | 190 | (1st Notice) Pursuant to Local Rule IC 2-1: that George C. Lombardi is in violation of Local Rule IC 2-1. Participation in the electronic filing system became mandatory for all attorneys effective January 1, 2006. You are required to register to file documents electronically in the Court's electronic filing system (CM/ECF) and the electronic service of pleadings and other papers. Please visit the Court's website to complete the registration for CM/ECF. (no image attached) (DRM) (Entered: 03/11/2019) (0) |
| Mar 11, 2019 | 191 | ORDER granting ECF No. 187 Corrected Joint Stipulation Regarding Agreement that DRL's Proposed ANDA Product Meets Certain Claim Limitations. Signed by Judge Miranda M. Du on 3/11/2019.(Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/11/2019) (0) |
| Mar 8, 2019 | 186 | Joint MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 03/08/2019) (0) |
| Mar 8, 2019 | 187 | Joint STIPULATION re Discovery Corrected Joint Stipulation Regarding Agreement that DRL's Proposed ANDA Product Meets Certain Claim Limitations re 186 Motion to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 03/08/2019) (0) |
| Feb 15, 2019 | 185 | ORDER granting ECF No. 184 Unopposed Motion to Substitute Hikma Pharmaceuticals International Limited for West-Ward Pharmaceuticals International Limited. Signed by Magistrate Judge Nancy J. Koppe on 2/15/2019.(Copies have been distributed pursuant to the NEF - KW) (Entered: 02/15/2019) (0) |
| Feb 14, 2019 | 184 | Unopposed MOTION substitute parties by Defendants Hikma Pharmaceuticals USA Inc., West-Ward Pharmaceuticals International Limited. Responses due by 2/28/2019. (Shaffer, Wayne) (Entered: 02/14/2019) (0) |
| Feb 6, 2019 | 182 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Claire A. Fundakowski and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-5420638) by Defendants Hikma Pharmaceuticals USA Inc., West-Ward Pharmaceuticals International Limited. (Shaffer, Wayne) (Entered: 02/06/2019) (0) |
| Feb 6, 2019 | 183 | ORDER approving ECF No. 182 Verified Petition for Permission to Practice Pro Hac Vice for Attorney Claire A. Fundakowski for Hikma Pharmaceuticals USA Inc. and West-Ward Pharmaceuticals International Limited and approving Designation of Local Counsel Wayne A. Shaffer. Signed by Judge Miranda M. Du on 2/6/2019. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - KW) (Entered: 02/07/2019) (0) |
| Jan 16, 2019 | 181 | TRANSCRIPT of Proceedings, 180 Order on Motion to Extend/Shorten Time,,,,,,,,,,,,,,,, Motion Hearing,,,,,,, held on 1-14-19, before Magistrate Judge Nancy J. Koppe. Court Reporter/Transcriber: Kathy French, KF@nvd.uscourts.gov. Any Redaction Request is due by 2/6/2019. Redacted Transcript Deadline is set for 2/16/2019. Release of the Transcript Restriction is set for 4/16/2019. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (KF) (Entered: 01/16/2019) (0) |
| Jan 14, 2019 | 179 | REPLY to Response to 168 Motion, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Declaration of Jordan Moran, # 2 Index of Exhibits, # 3 Exhibit A, # 4 Exhibit B, # 5 Exhibit C, # 6 Certificate of Service) (Smith, Jason) (Entered: 01/14/2019) (0) |
| Jan 14, 2019 | 180 | MINUTES OF PROCEEDINGS - Telephonic Motion Hearing re: 165 Motion to Modify Discovery Plan and Scheduling Order and 168 Motion to Amend Preliminary Validity Contentions held on 1/14/2019 before Magistrate Judge Nancy J. Koppe. Crtrm Administrator: A. Caytuero; Pla Counsel: Christopher N. Sipes, Esq., Jason D. Smith, Esq., & Michael Kennedy, Esq.; Def Counsel: Constance S. Huttner, Esq., Michael D. Rounds, Esq., Caroline Sun, Esq., Wayne A. Shaffer, Esq., Alan Clement, Esq., & Eimeric Reig-Plessis, Esq.; Time of Hearing: 2:06:14 - 2:30:43; Electronic Court Recorder Operator: FTR; Recording start and end times: 2:06 PM - 2:30 PM; Courtroom: 3A; Plaintiffs' counsel and Defendants' counsel are present via telephonic appearance. The Court makes preliminary statements and hears the representations of counsel as to 168 Motion to Amend Preliminary Validity Contentions first, then 165 Motion to Modify Discovery Plan and Scheduling Order. The Court makes its finding for the record. IT IS ORDERED that 168 Motion to Amend Preliminary Validity Contentions is GRANTED. IT IS FURTHER ORDERED that 165 Motion to Modify Discovery Plan and Scheduling Order is GRANTED. IT IS FURTHER ORDERED that the proposed modification dates provided on page 6 of 165 Motion to Modify Discovery Plan and Scheduling Order will be the new deadlines. Expert Discovery is due by July 10, 2019. Dispositive Motions are due by August 9, 2019. The Court will defer ruling on the issue of patient data and what the discovery should be, as stated on the record. The Court advises the parties to file the appropriate motion after a meet and confer. IT IS FURTHER ORDERED that Attorney Alan Clement's request for one 7-hour deposition limited to new information provided by Plaintiffs is GRANTED. Court adjourns. (no image attached) (Copies have been distributed pursuant to the NEF - AC) (Entered: 01/14/2019) (0) |
| Jan 10, 2019 | 178 | RESPONSE to 168 Motion, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Replies due by 1/17/2019. (Attachments: # 1 Declaration Caroline Sun, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Exhibit E, # 7 Exhibit F, # 8 Exhibit G, # 9 Exhibit H, # 10 Exhibit I, # 11 Exhibit J, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V) (Rounds, Michael) (Entered: 01/10/2019) (0) |
| Jan 9, 2019 | 176 | STIPULATION FOR EXTENSION OF TIME (Third Request) Stipulation Regarding One-Day Extension of the Deadline to Serve Opening Expert Reports to January 10, 2019 by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 01/09/2019) (0) |
| Jan 9, 2019 | 177 | ORDER - The Court GRANTS the parties' stipulation (ECF No. 176 ). The expert disclosure deadline is extended to January 14, 2019. Additionally, the Court SETS a telephonic hearing on Defendants' motion to modify the discovery plan and scheduling order (ECF No. 165 ) on January 14, 2019, at 2:00 p.m. The parties shall call the Court conference line at 877-402-9757 at least five minutes prior to the hearing. The conference code is 6791056. Signed by Magistrate Judge Nancy J. Koppe on 1/9/2019. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/09/2019) (0) |
| Jan 3, 2019 | 173 | REPLY to Response to 165 Motion to Extend/Shorten Time, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 01/03/2019) (0) |
| Jan 3, 2019 | 174 | ORDER approving ECF No. 171 Verified Petition for Permission to Practice Pro Hac Vice as to George C. Lombardi and approving Designation of Local Counsel Wayne A. Shaffer. Signed by Judge Miranda M. Du on 1/3/2019. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - LH) (Entered: 01/04/2019) (0) |
| Jan 3, 2019 | 175 | ORDER approving ECF No. 172 Verified Petition for Permission to Practice Pro Hac Vice as to Eimeric Reig-Plessis and approving Designation of Local Counsel Wayne A. Shaffer. Signed by Judge Miranda M. Du on 1/3/2019. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - LH) (Entered: 01/04/2019) (0) |
| Jan 2, 2019 | 171 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by George C. Lombardi and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-5377474) by Defendants Hikma Pharmaceuticals USA Inc., West-Ward Pharmaceuticals International Limited. (Shaffer, Wayne) (Entered: 01/02/2019) (0) |
| Jan 2, 2019 | 172 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Eimeric Reig-Plessis and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-5377500) by Defendants Hikma Pharmaceuticals USA Inc., West-Ward Pharmaceuticals International Limited. (Shaffer, Wayne) (Entered: 01/02/2019) (0) |
| Dec 28, 2018 | 169 | RESPONSE to 168 Motion, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Replies due by 1/4/2019. (Rounds, Michael) (Entered: 12/28/2018) (0) |
| Dec 28, 2018 | 170 | RESPONSE to 169 Response, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 12/28/2018) (0) |
| Dec 27, 2018 | 167 | RESPONSE to 165 Motion to Extend/Shorten Time, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 1/3/2019. (Attachments: # 1 Declaration of Alaina Whitt, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Certificate of Service) (Smith, Jason) (Entered: 12/27/2018) (0) |
| Dec 27, 2018 | 168 | MOTION Motion to Amend Preliminary Validity Contentions by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 1/10/2019. (Attachments: # 1 Declaration of Alaina Whitt, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D, # 6 Certificate of Service) (Smith, Jason) (Entered: 12/27/2018) (0) |
| Dec 20, 2018 | 166 | ORDER that pending before the Court is ECF No. 165 Motion to modify the discovery plan and scheduling order. A response to be filed no later than 12/27/2018 and any reply be filed no later than 1/3/2019. Signed by Magistrate Judge Nancy J. Koppe on 12/20/2018. (Copies have been distributed pursuant to the NEF - KW) (Entered: 12/20/2018) (0) |
| Dec 19, 2018 | 165 | Emergency MOTION to Extend Time (Second Request) re 60 Scheduling Order by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Attachments: # 1 Declaration Caroline Sun, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3) (Rounds, Michael) (Entered: 12/19/2018) (0) |
| Dec 18, 2018 | 164 | ORDER granting ECF No. 163 Motion to Withdraw as Counsel. Signed by Magistrate Judge Nancy J. Koppe on 12/18/2018. Attorney Dmitry Shelhoff terminated. (Copies have been distributed pursuant to the NEF - KR) (Entered: 12/18/2018) (0) |
| Dec 17, 2018 | 163 | NOTICE of Withdrawal of Counsel by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 12/17/2018) (0) |
| Dec 12, 2018 | 161 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Charles B. Klein and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-5356918) by Defendant Hikma Pharmaceuticals USA Inc.. (Shaffer, Wayne) (Entered: 12/12/2018) (0) |
| Dec 12, 2018 | 162 | ORDER granting ECF No. 161 Verified Petition for Permission to Practice Pro Hac Vice by Attorney Charles B. Klein for Hikma Pharmaceuticals USA Inc, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 12/12/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 12/13/2018) (0) |
| Dec 3, 2018 | 158 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 12/3/2018. Good cause appearing, because the parties' stipulation (ECF No. 156) contains confidential business information, the Court grants Defendants' Motion to Seal (ECF No. 155 ). (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 12/03/2018) (0) |
| Dec 3, 2018 | 159 | ORDER granting ECF No. 156 Stipulation Regarding Argeement that DRL's Proposed ANDA Product Meets Certain Claim Limitations. Signed by Judge Miranda M. Du on 12/3/2018.(Copies have been distributed pursuant to the NEF - DRM) (Entered: 12/03/2018) (0) |
| Dec 3, 2018 | 160 | (1st Notice) Pursuant to Local Rule IC 2-1: that Dmitry Shelhoff is in violation of Local Rule IC 2-1. Participation in the electronic filing system became mandatory for all attorneys effective January 1, 2006. You are required to register to file documents electronically in the Court's electronic filing system (CM/ECF) and the electronic service of pleadings and other papers. Please visit the Court's website to complete the registration for CM/ECF. (no image attached) (DRM) (Entered: 12/03/2018) (0) |
| Nov 30, 2018 | 155 | MOTION to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 11/30/2018) (0) |
| Nov 30, 2018 | 156 | Joint STIPULATION Regarding Agreement That DRL's Proposed ANDA Product Meets Certain Claim Limitations re 155 Motion to Seal by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 11/30/2018) (0) |
| Oct 23, 2018 | 154 | ORDER APPROVING ECF no. 153 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Jordan L. Moran for Amarin Pharma, Inc. & Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Judge Miranda M. Du on 10/23/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - DRM) (Entered: 10/23/2018) (0) |
| Oct 22, 2018 | 153 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Jordan L. Moran and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-5292394) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 10/22/2018) (0) |
| Oct 15, 2018 | 152 | ORDER approving ECF No. 151 Verified Petition for Permission to Practice Pro Hac Vice as to attorney Han Park on behalf of Plaintiff Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Judge Miranda M. Du on 10/15/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - KW) (Entered: 10/16/2018) (0) |
| Oct 12, 2018 | 151 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Han Park and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-5279421) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 10/12/2018) (0) |
| Oct 9, 2018 | 150 | MINUTES OF PROCEEDINGS - Settlement Conference held on 10/9/2018 before Magistrate Judge Nancy J. Koppe. Pla Counsel: Christopher Sipes, Alaina Whitt, Nick Santoro ; Pla Rep Joe Kennedy present; Def Counsel: Alan Clement, Myoka Goodin, Constance Huttner, Frank Rodriguez; Def Reps Ed Pardon and Anjum Swaroop present; Time of Hearing: 9:30 a.m. -12:50 p.m.; The Court, the parties, and counsel conferred but no settlement was reached. (no image attached) (Copies have been distributed pursuant to the NEF - SR) (Entered: 10/09/2018) (0) |
| Oct 5, 2018 | 148 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Frank D. Rodriguez and DESIGNATION of Local Counsel Michael D. Rounds (Filing fee $ 250 receipt number 0978-5270086) by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 10/05/2018) (0) |
| Oct 5, 2018 | 149 | ORDER approving ECF No. 148 Verified Petition for Permission to Practice Pro Hac Vice as to attorney Frank D. Rodriguez on behalf of Defendant Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. and approving Designation of Local Counsel Michael D. Rounds. Signed by Judge Miranda M. Du on 10/5/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov(Copies have been distributed pursuant to the NEF - KW) (Entered: 10/09/2018) (0) |
| Sep 14, 2018 | 145 | First STIPULATION re Discovery Joint Stipulation to Modify Discovery Plan and Scheduling Order re 60 Scheduling Order by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 09/14/2018) (0) |
| Sep 14, 2018 | 146 | SCHEDULING ORDER pursuant to ECF No. 145 Joint Stipulation to Modify Discovery Plan and Scheduling Order. Discovery due by 5/10/2019. Dispositive Motions due by 6/10/2019. Signed by Magistrate Judge Nancy J. Koppe on 9/14/2018. (Copies have been distributed pursuant to the NEF - LH) (Entered: 09/14/2018) (0) |
| Sep 14, 2018 | 147 | NOTICE PURSUANT TO LOCAL RULE IB 2-2: In accordance with 28 USC § 636(c) and FRCP 73, the parties in this action are provided with a link to the "AO 85 Notice of Availability, Consent, and Order of Reference - Exercise of Jurisdiction by a U.S. Magistrate Judge" form on the Court's website - www.nvd.uscourts.gov. AO 85 Consent forms should NOT be electronically filed. Upon consent of all parties, counsel are advised to manually file the form with the Clerk's Office. (A copy of form AO 85 has been mailed to parties not receiving electronic service.)NOTICE OF GENERAL ORDER 2013-1 AND OPPORTUNITY FOR EXPEDITED TRIAL SETTING: The parties in this action are provided with a link to General Order 2013-1 and the USDC Short Trial Rules on the Court's website - www.nvd.uscourts.gov. If the parties agree that this action can be ready for trial within 180 days and that a trial of this matter would take 3 days or less, the parties should consider participation in the USDC Short Trial Program. If the parties wish to be considered for entry into the Court's Short Trial Program, they should execute and electronically file with USDC Short Trial Form 4(a)(1) or Form 4(a)(2). (no image attached) (LH) (Entered: 09/14/2018) (0) |
| Sep 12, 2018 | 143 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Dmitry Shelhoff and DESIGNATION of Local Counsel Michael D. Rounds (Filing fee $ 250 receipt number 0978-5237468) by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Rounds, Michael) (Entered: 09/12/2018) (0) |
| Sep 12, 2018 | 144 | ORDER approving ECF No. 143 Verified Petition for Permission to Practice Pro Hac Vice as to Dmitry Shelhoff on behalf of Dr. Reddy's Laboratories, Inc. (and Ltd.) and approving Designation of Local Counsel Michael D. Rounds. Signed by Judge Miranda M. Du on 9/12/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - LH) (Entered: 09/13/2018) (0) |
| Aug 30, 2018 | 142 | ORDER that due to conflicting duties of the Court, the settlement conference set in this case is hereby ADVANCED to 9:30 a.m. on October 9, 2018. Settlement statements shall be submitted by 3:00 p.m. on October 2, 2018. All other requirements in the order at Docket No. 136 continue to govern. Signed by Magistrate Judge Nancy J. Koppe on 8/30/2018. (Copies have been distributed pursuant to the NEF - LH) (Entered: 08/30/2018) (0) |
| Aug 21, 2018 | 141 | ORDER granting ECF No. 139 Joint Request for Exception to Settlement Conference Attendance Requirement. Signed by Magistrate Judge Nancy J. Koppe on 8/21/2018.(Copies have been distributed pursuant to the NEF - KW) (Entered: 08/21/2018) (0) |
| Aug 20, 2018 | 139 | Joint STIPULATION Joint Request for Exception to Settlement Conference Attendance Requirement re 136 Order Setting Settlement Conference,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Proposed Order) (Smith, Jason) (Entered: 08/20/2018) (0) |
| Aug 20, 2018 | 140 | NOTICE of Corrected Image/Document re 139 Stipulation, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Service of corrected image is attached.) (Attachments: # 1 Proposed Order) (Smith, Jason) (Entered: 08/20/2018) (0) |
| Aug 15, 2018 | 138 | ORDER granting ECF No. 137 Motion to remove attorney John Rozendaal, Michael Joffre, Chandrika Vira, John P. Desmond, Brian R. Irvine, Justin James Bustos from the Electronic Service List in this case on behalf of Teva Pharmaceuticals USA, Inc. Signed by Magistrate Judge Nancy J. Koppe on 8/15/2018. (Copies have been distributed pursuant to the NEF - LH) (Entered: 08/15/2018) (0) |
| Aug 14, 2018 | 137 | MOTION to remove attorney John Rozendaal, Michael Joffre, Chandrika Vira, John P. Desmond, Brian R. Irvine, Justin James Bustos from the Electronic Service List in this case by Defendants Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Counter Claimants Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Desmond, John) (Entered: 08/14/2018) (0) |
| Aug 13, 2018 | 136 | ORDER that SETS a settlement conference for 10/11/2018 at 9:30 AM in LV Chambers before Magistrate Judge Nancy J. Koppe. The settlement conference statements shall be submitted, in an envelope marked "Confidential," directly to the undersigned's box in the Clerk's Office not later than 10/4/2018 at 3:00 PM. DO NOT SERVE A COPY ON OPPOSING COUNSEL. (See order for further details and instructions). Signed by Magistrate Judge Nancy J. Koppe on 8/13/2018. (Copies have been distributed pursuant to the NEF - LH) (Entered: 08/13/2018) (0) |
| Aug 10, 2018 | 135 | ORDER that the Court has reviewed the arguments and cases and determines that they do not warrant discussion as they do not affect the outcome of this claim construction. Signed by Judge Miranda M. Du on 8/10/2018. (Copies have been distributed pursuant to the NEF - KW) (Entered: 08/10/2018) (0) |
| Aug 2, 2018 | 132 | ORDER granting ECF No. 131 Unopposed Motion to Substitute Hikma Pharmaceuticals USA, Inc for West-Ward Pharmaceuticals Corp. Signed by Magistrate Judge Nancy J. Koppe on 8/2/2018. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 08/02/2018) (0) |
| Aug 2, 2018 | 133 | (1st Notice) Pursuant to Local Rule IC 2-1: that Eric R. Sonnenschein is in violation of Local Rule IC 2-1. Participation in the electronic filing system became mandatory for all attorneys effective January 1, 2006. You are required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) program and the electronic service of pleadings. Please visit the Court's website to register for CM/ECF. (no image attached) (DRM) (Entered: 08/02/2018) (0) |
| Aug 2, 2018 | 134 | (1st Notice) Pursuant to Local Rule IC 2-1: that Alaina M. Whitt is in violation of Local Rule IC 2-1. Participation in the electronic filing system became mandatory for all attorneys effective January 1, 2006. You are required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) program and the electronic service of pleadings. Please visit the Court's website to register for CM/ECF. (no image attached) (DRM) (Entered: 08/02/2018) (0) |
| Aug 1, 2018 | 131 | UNOPPOSED MOTION AND PROPOSED ORDER TO SUBSTITUTE HIKMA PHARMACEUTICALS USA INC. FOR WEST-WARD PHARMACEUTICALS CORP. by Counter Claimant West-Ward Pharmaceuticals Corporation, Defendant West-Ward Pharmaceuticals Corporation. (Goodin, Myoka) (Entered: 08/01/2018) (0) |
| Jul 31, 2018 | 130 | TRANSCRIPT of Proceedings, 121 Markman/Claim Construction Hearing held on 4/24/2018, before Judge Miranda M. Du. Court Reporter/Transcriber: Margaret Griener, MG@nvd.uscourts.gov. Any Redaction Request is due by 8/21/2018. Redacted Transcript Deadline is set for 8/31/2018. Release of the Transcript Restriction is set for 10/29/2018. Before release date, the transcript may be viewed at the court public terminal or purchased through the reporter/transcriber. Transcript Order form is available on court website. After that date it may be obtained through the court reporter or PACER. (MG) (Entered: 07/31/2018) (0) |
| May 25, 2018 | 128 | CONSENT JUDGMENT pursuant to ECF No. 127 Stipulation. Signed by Judge Miranda M. Du on 5/25/2018. (Copies have been distributed pursuant to the NEF - LH) Modified on 5/25/2018 to correct doc title(LH). (Entered: 05/25/2018) (0) |
| May 25, 2018 | 129 | NOTICE of Docket Correction to ECF No. 128 Order on Stipulated/Consent Judgment : corrected document title (no image attached) (LH) (Entered: 05/25/2018) (0) |
| May 24, 2018 | 127 | STIPULATED/CONSENT JUDGMENT by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 05/24/2018) (0) |
| May 4, 2018 | 126 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 5/4/2018. Please take notice that Judge Du has made changes to her Civil Standing Order. The most current Civil Standing Order is posted on the U.S. District Court, District of Nevada public website and may be accessed directly via this hyperlink: www.nvd.uscourts.gov (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 05/04/2018) (0) |
| Apr 26, 2018 | 125 | NOTICE of Filing Exhibit B Relating to April 24, 2018 Claim Construction Hearing by West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited. (Attachments: # 1 Exhibit) (Shaffer, Wayne) (Entered: 04/26/2018) (0) |
| Apr 25, 2018 | 123 | CERTIFICATE of Compliance re 112 Order by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited (Smith, Jason) (Entered: 04/25/2018) (0) |
| Apr 25, 2018 | 124 | EXHIBIT Notice of Filing of Exhibit A to 121 Markman/Claim Construction Hearing,,,,,,,,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Certificate of Service) (Smith, Jason) (Entered: 04/25/2018) (0) |
| Apr 24, 2018 | 121 | MINUTES OF PROCEEDINGS - Markman/Claim Construction Hearing held on 4/24/2018 before Judge Miranda M. Du. Crtrm Administrator: Peggie Vannozzi; Pla Counsel: Christopher Sipes, Alaina Whitt, Michael Kennedy, Eric Sonnenschein, Jason Smith; Def Counsel: for Defendant West-Ward: Alan Clement, Myoka Goodin, Wayne Shaffer; for Defendant Teva: Chandrika Vira, John Desmond; For Defendant Dr. Reddy's Labs: caroline Sun, Michael Rounds.; Court Reporter: Margaret Griener; Time of Hearing: 9:02 AM - 2:43 PM; Courtroom: 5; The Court makes preliminary statements. Mr. Sipes and Mr. Clement present tutorials. Mr. Clement advises that the parties have agreed to stipulate to Plaintiff's proposed construction of the term "pharmaceutical composition." Mr. Sipes concurs. Mr. Sipes and Mr. Clement present argument on the term "Concurrent/concomitant therapy." Ms. Whitt and Mr. Clement present argument on the term "administering/ administered." Recess: 10:45 AM 11:14 AM. Mr. Clement advises the Court that counsel did not reach an agreement on the construction of the term "administering/administered." Ms. Whitt and Mr. Clement present additional argument on that term. Mr. Sipes and Mr. Clement present argument on the terms "without substantially increasing LDL-C," "substantially no increase or a reduction in fasting LDL-C," "substantially no increase in LDL-C." Mr. Kennedy and Mr. Clement present argument on the issue of "effective" terms. The Court discusses with counsel the claims that are remaining. Recess: 12:35 PM 2:02 PM. The Court directs Plaintiff to file its PowerPoint presentation as exhibit A to this proceeding. The Court directs Defendant to file its PowerPoint presentation as exhibit B to this hearing. Mr. Kennedy and Mr. Clement present argument on the terms "compared to placebo" and "placebo control." Mr. Sipes and Mr. Clement present argument on the term "Identifying Group of Subjects." The Court makes findings for the record and determines that the term does not need construction. Counsel agree that there is no need for the term "patient population" to be construed. The Court thanks counsel for their presentations. The matter stands submitted. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 04/24/2018) (0) |
| Apr 24, 2018 | 122 | ADDENDUM to 102 Response,,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited, Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited. (Attachments: # 1 Exhibit 1, Transcript of 2/15/2018 Deposition of Michael Miller, M.D.) (Goodin, Myoka) (Entered: 04/24/2018) (0) |
| Apr 18, 2018 | 120 | ORDER granting ECF No. 119 Unopposed Motion to File Supplement to Defendants' Responsive Claim Construction Brief. Signed by Judge Miranda M. Du on 4/18/2018.(Copies have been distributed pursuant to the NEF - KW) (Entered: 04/19/2018) (0) |
| Apr 17, 2018 | 119 | UNOPPOSED MOTION for leave to file Supplement to Defendants' Responsive Claim Construction Brief re 102 Response,,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited, Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited. (Attachments: # 1 Declaration of Myoka Kim Goodin in support of Unopposed Request for Leave to File Supplement to Defendants' Responsive Claim Construction Brief, # 2 Exhibit A, Supplement to Defendants' Responsive Claim Construction Brief, # 3 Exhibit 1 to Supplement, Transcript of Deposition of Michael Miller, M.D., # 4 Exhibit B, Proposed Order) (Goodin, Myoka) (Entered: 04/17/2018) (0) |
| Apr 4, 2018 | 115 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Alaina M. Whitt and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-5036853) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 04/04/2018) (0) |
| Apr 4, 2018 | 116 | MOTION/VERIFIED PETITION for Permission to Practice Pro Hac Vice by Eric R. Sonnenschein and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-5036859) by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 04/04/2018) (0) |
| Apr 4, 2018 | 117 | ORDER granting ECF No. 115 Verified Petition for Permission to Practice Pro Hac Vice by Alaina M. Whitt for Amarin Pharma Inc and Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 4/4/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 04/05/2018) (0) |
| Apr 4, 2018 | 118 | ORDER granting ECF No. 116 Verified Petition for Permission to Practice Pro Hac Vice by Eric R. Sonnenschein for Amarin Pharma Inc and Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 4/4/2018. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 04/05/2018) (0) |
| Mar 5, 2018 | 114 | NOTICE of Change of Address by Wayne A Shaffer. (Shaffer, Wayne) (Entered: 03/05/2018) (0) |
| Feb 2, 2018 | 113 | REPLY to 102 Response,,, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Declaration of Michael Miller, # 2 Declaration of Megan P. Keane, # 3 Exhibit 33, # 4 Certificate of Service) (Smith, Jason) (Entered: 02/02/2018) (0) |
| Jan 30, 2018 | 112 | ORDER granting ECF No. 111 Proposed Discovery Plan/Scheduling Order. Signed by Magistrate Judge Nancy J. Koppe on 1/30/2018. (Copies have been distributed pursuant to the NEF - KW) (Entered: 01/30/2018) (0) |
| Jan 29, 2018 | 111 | PROPOSED Discovery Plan/Scheduling Order by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited (Attachments: # 1 Certificate of Service) (Smith, Jason) (Entered: 01/29/2018) (0) |
| Jan 4, 2018 | 109 | ANSWER to Defendant's Counterclaims (ECF No. 106 ) filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.(Smith, Jason) Modified on 1/5/2018. (BLG). (Entered: 01/04/2018) (0) |
| Jan 4, 2018 | 110 | ORDER granting ECF No. 108 Stipulation to Extend Time for Plaintiffs to File Their Reply claim Construction Brief. Reply brief due by 2/2/2018. Signed by Judge Miranda M. Du on 1/4/2018. (Copies have been distributed pursuant to the NEF - KW) (Entered: 01/05/2018) (0) |
| Jan 3, 2018 | 108 | STIPULATION FOR EXTENSION OF TIME (First Request) for Plaintiffs to file their Reply Claim Construction Brief re 60 Scheduling Order by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 01/03/2018) (0) |
| Dec 18, 2017 | 106 | ANSWER to 1 Complaint,,, ANSWER TO COMPLAINT AND COUNTERCLAIM, Case No. 2:17-cv-02641-MMD-NJK filed by Teva Pharmaceuticals USA, Inc..(Bustos, Justin) (Entered: 12/18/2017) (0) |
| Dec 18, 2017 | 107 | ORDER GRANTING Defendant Teva's ECF No. 95 Motion to vacate settlement conference : The Court hereby VACATES the settlement conference on January 8, 2018. The Court will set a post-claim construction settlement conference after a claim construction order has been issued. Signed by Magistrate Judge Nancy J. Koppe on 12/18/2017. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 12/18/2017) (0) |
| Dec 14, 2017 | 104 | REPLY to 95 Motion by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. (Bustos, Justin) (Entered: 12/14/2017) (0) |
| Dec 14, 2017 | 105 | CERTIFICATE OF SERVICE for 104 Reply to 95 Motion by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. (Bustos, Justin) Modified on 12/15/2017 text & link added. (BLG). (Entered: 12/14/2017) (0) |
| Dec 13, 2017 | 103 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du on 12/13/2017. By Deputy Clerk: Peggie Vannozzi. Markman/Claim Construction Hearing is set for 4/24/2018 at 09:00 AM in Reno Courtroom 5 before Judge Miranda M. Du. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 12/13/2017) (0) |
| Dec 12, 2017 | 100 | RESPONSE to 99 Response, 95 Motion by Defendants West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited. (Shaffer, Wayne) (Entered: 12/12/2017) (0) |
| Dec 12, 2017 | 101 | RESPONSE to 95 Motion by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Replies due by 12/19/2017. (Rounds, Michael) (Entered: 12/12/2017) (0) |
| Dec 12, 2017 | 102 | RESPONSE to 89 Opening Brief,,,, by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited, Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited. (Attachments: # 1 Declaration Ronald H. Wharton, M.D., # 2 Index of Exhibits, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18, # 21 Exhibit 19, # 22 Exhibit 20, # 23 Exhibit 21) (Bustos, Justin) (Entered: 12/12/2017) (0) |
| Dec 8, 2017 | 97 | ORDER granting ECF No. 94 Stipulation for Exception to Settlement Conference Attendance Requirement. Signed by Magistrate Judge Nancy J. Koppe on 12/8/2017.(Copies have been distributed pursuant to the NEF - DRM) (Main Document 97 replaced on 12/8/2017) (DRM). (Entered: 12/08/2017) (0) |
| Dec 8, 2017 | 98 | MINUTE ORDER IN CHAMBERS of the Honorable Magistrate Judge Nancy J. Koppe on 12/8/2017. Pending before the Court is 95 Motion to Adjourn Pre-Claim-Construction Settlement Conference, filed by Defendant Teva Pharmaceuticals. All other parties shall file a response no later than 12/12/2017. Any reply shall be filed no later than 12/14/2017. (no image attached) (Copies have been distributed pursuant to the NEF - NJK) (Entered: 12/08/2017) (0) |
| Dec 8, 2017 | 99 | RESPONSE to 95 Motion by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Replies due by 12/15/2017. (Smith, Jason) (Entered: 12/08/2017) (0) |
| Dec 6, 2017 | 94 | Joint STIPULATION Joint Request for Exception to Settlement Conference Attendance Requirement re 92 Order Setting Settlement Conference, by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Proposed Order) (Smith, Jason) (Entered: 12/06/2017) (0) |
| Dec 6, 2017 | 95 | MOTION Request to Adjourn Pre-Claim-Construction Settlement Conference by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. Responses due by 12/20/2017. (Bustos, Justin) (Entered: 12/06/2017) (0) |
| Dec 6, 2017 | 96 | Submission of PROPOSED ORDER Re: 95 Motion by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. (Bustos, Justin) Modified on 12/7/2017 link added. (BLG). (Entered: 12/06/2017) (0) |
| Nov 29, 2017 | 92 | ORDER setting Pre-claim Construction Settlement Conference. Settlement Conference set for 1/8/2018 at 9:30 AM in LV Chambers before Magistrate Judge Nancy J. Koppe. Signed by Magistrate Judge Nancy J. Koppe on 11/29/2017. (Copies have been distributed pursuant to the NEF - LH) (Entered: 11/29/2017) (0) |
| Nov 29, 2017 | 93 | ORDER that the parties are to file a stipulation seven days after entry of the claim construction order and seven days after the filing of the pretrial order. Signed by Magistrate Judge Nancy J. Koppe on 11/29/2017. (Copies have been distributed pursuant to the NEF - LH) (Entered: 11/29/2017) (0) |
| Nov 7, 2017 | 91 | ORDER granting ECF No. 86 Motion to Consolidate Cases : Clerk is directed to consolidate Case No. 2:17-cv-02641-RFB-GWF with Case Nos. 2:16-cv-02525-MMD-NJK, 2:16:cv-02562-MMD-NJK, and 2:16-cv-02658-MMD-NJK, and all future pleadings must bear Case No. 2:16-cv-02525-MMD-NJK. Signed by Judges Miranda M. Du and Richard F. Boulware, II on 11/6/2017. (Copies have been distributed pursuant to the NEF - DRM) Modified on 11/7/2017 to correct judge's initials for base case (DRM). (Entered: 11/07/2017) (0) |
| Nov 2, 2017 | 90 | EXHIBIT(s) Index of Exhibits to Plaintiffs' Opening Markman Brief to 89 Opening Brief,,,, ; filed by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 11/02/2017) (0) |
| Nov 1, 2017 | 88 | ORDER granting ECF No. 87 Stipulation to extend time for substantial completion of document production; deadline continued to 12/15/2017. Signed by Magistrate Judge Nancy J. Koppe on 11/1/2017. (Copies have been distributed pursuant to the NEF - KW) (Entered: 11/01/2017) (0) |
| Nov 1, 2017 | 89 | OPENING BRIEF Plaintiffs' Opening Markman Brief by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Declaration of Michael Miller, # 2 Declaration of Megan P. Keane, # 3 Exhibit 1, # 4 Exhibit 2, # 5 Exhibit 3, # 6 Exhibit 4, # 7 Exhibit 5, # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16, # 19 Exhibit 17, # 20 Exhibit 18 (pgs 1-64), # 21 Exhibit 18 (pgs 65-108), # 22 Exhibit 18 (pgs 109-153), # 23 Exhibit 18 (pgs 154-234), # 24 Exhibit 18 (pgs 235-279), # 25 Exhibit 18 (pgs 280-324), # 26 Exhibit 18 (pgs 325-369), # 27 Exhibit 19, # 28 Exhibit 20 (pgs 1-100), # 29 Exhibit 20 (pgs 101-280), # 30 Exhibit 21, # 31 Exhibit 22, # 32 Exhibit 23, # 33 Exhibit 24, # 34 Exhibit 25, # 35 Exhibit 26, # 36 Exhibit 27, # 37 Exhibit 28, # 38 Exhibit 29, # 39 Exhibit 30, # 40 Exhibit 31, # 41 Exhibit 32, # 42 Certificate of Service)(Santoro, Nicholas) (Entered: 11/01/2017) (0) |
| Oct 31, 2017 | 86 | Joint MOTION to Consolidate Cases Joint Motion to Consolidate by Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited and Defendant Teva Pharmaceuticals USA, Inc. by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 11/14/2017. (Santoro, Nicholas) (Entered: 10/31/2017) (0) |
| Oct 31, 2017 | 87 | STIPULATION FOR EXTENSION OF TIME (First Request) re 60 Scheduling Order ; Stipulation and Order to Extend Time for Substantial Completion of Document Production by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 10/31/2017) (0) |
| Oct 5, 2017 | 85 | ORDER granting ECF No. 84 , Joint Motion for Increased Page Limits for Claim Construction Briefing. Good cause appearing, the joint motion for increased page limits for claim construction briefing (ECF No. 84 ) is granted. The page limits for the claim construction briefs are as follows: 1) 40 pages for the opening claim; 2) 50 pages for the construction response brief; 3) 20 pages for the claim construction reply brief. Signed by Judge Miranda M. Du on 10/5/2017. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 10/05/2017) (0) |
| Oct 4, 2017 | 84 | Joint MOTION for Leave to File Excess Pages re 60 Scheduling Order Joint Motion for Increased Page Limits for Claim Construction Briefing by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Certificate of Service)(Santoro, Nicholas) (Entered: 10/04/2017) (0) |
| Sep 29, 2017 | 83 | STATEMENT of Joint Claim Construction and Prehearing Statement Pursuant to LPR 1-15 by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Index of Exhibits, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Certificate of Service)(Santoro, Nicholas) (Entered: 09/29/2017) (0) |
| Jul 18, 2017 | 82 | CERTIFICATE of Compliance filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 07/18/2017) (0) |
| Jul 13, 2017 | 81 | ORDER approving ECF No. 80 Verified Petition for Permission to Practice Pro Hac Vice by Beth Finkelstein for Dr. Reddy's Labs Inc and Dr. Reddy's Labs Ltd, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 7/12/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 07/13/2017) (0) |
| Jul 12, 2017 | 80 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Beth Finkelstein and DESIGNATION of Local Counsel Michael D. Rounds (Filing fee $ 250 receipt number 0978-4687073) filed by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. . (Rounds, Michael) (Entered: 07/12/2017) (0) |
| Mar 20, 2017 | 76 | ORDER APPROVING ECF No. 75 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Michael E. Joffre for Teva Pharmaceuticals USC Inc., and approving Designation of Local Counsel John P. Desmond. Signed by Judge Miranda M. Du on 3/20/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/20/2017) (0) |
| Mar 20, 2017 | 77 | ORDER APPROVING ECF No. 73 Verified Petition for Permission to Practice Pro Hac Vice of attorney J.C. Rozendaal for Teva Pharmaceuticals USA Inc. and approving Designation of Local Counsel John P. Desmond. Signed by Judge Miranda M. Du on 3/20/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/20/2017) (0) |
| Mar 20, 2017 | 78 | ORDER APPROVING ECF No. 74 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Chandrika Vira for Teva Pharmaceuticals USA, Inc. and approving Designation of Local Counsel John P. Desmond. Signed by Judge Miranda M. Du on 3/20/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/20/2017) (0) |
| Mar 20, 2017 | 79 | ORDER granting ECF No. 72 Stipulation for Substitution of Counsel : The law firm of Dickinson Wright PLLC substituted in the place and stead of Pisanelli Bice PLLC; for Teva Pharmaceuticals USA Inc. Signed by Magistrate Judge Nancy J. Koppe on 3/20/2017. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 03/20/2017) (0) |
| Mar 17, 2017 | 71 | NOTICE of Appearance by attorney John Patrick Desmond on behalf of Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. NOTICE OF APPEARANCE OF JOHN P. DESMOND AND BRIAN R. IRVINE (Desmond, John) (Entered: 03/17/2017) (0) |
| Mar 17, 2017 | 72 | STIPULATION AND [PROPOSED] ORDER PERMITTING SUBSTITUTION OF COUNSEL by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. (Desmond, John) (Entered: 03/17/2017) (0) |
| Mar 17, 2017 | 73 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by J.C. Rozendaal and DESIGNATION of Local Counsel John P. Desmond (Filing fee $ 250 receipt number 0978-4523318) filed by Defendants Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc. . (Desmond, John) (Entered: 03/17/2017) (0) |
| Mar 17, 2017 | 74 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Chandrika Vira and DESIGNATION of Local Counsel John P. Desmond (Filing fee $ 250 receipt number 0978-4523342) filed by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc. . (Desmond, John) (Entered: 03/17/2017) (0) |
| Mar 17, 2017 | 75 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Michael E. Joffre and DESIGNATION of Local Counsel John P. Desmond (Filing fee $ 250 receipt number 0978-4523354) filed by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc. . (Desmond, John) (Entered: 03/17/2017) (0) |
| Mar 16, 2017 | 69 | ORDER approving ECF No. 68 Stipulation and [Proposed] Discovery Confidentiality. Signed by Magistrate Judge Nancy J. Koppe on 03/16/2017. (Copies have been distributed pursuant to the NEF - KW) (Entered: 03/16/2017) (0) |
| Mar 16, 2017 | 70 | ORDER that counsel shall comply with the requirements of Local Rule IA 10-5, the Ninth Circuits decision in Kamakana, 447 F.3d 1172, and the procedures outlined above, with respect to any documents filed under seal. To the extent any aspect of the stipulated protective order may conflict with this order or Local Rule IA 10-5, that aspect of the stipulated protective order is hereby superseded with this order. IT IS SO ORDERED. Signed by Magistrate Judge Nancy J. Koppe on 03/16/2017. (Copies have been distributed pursuant to the NEF - KW) (Entered: 03/16/2017) (0) |
| Mar 15, 2017 | 68 | STIPULATION Stipulation and [Proposed] Discovery Confidentiality Order by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Attachments: # 1 Exhibit A)(Santoro, Nicholas) (Entered: 03/15/2017) (0) |
| Mar 9, 2017 | 67 | ORDER approving ECF No. 56 Verified Petition for Permission to Practice Pro Hac Vice by Alan B. Clement for West-Ward Pharmaceuticals Corp and West-Ward Pharmaceuticals International Limited, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 3/9/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 03/09/2017) (0) |
| Mar 8, 2017 | 66 | NOTICE of Corrected Image/Document re 56 Verified Petition, by Defendants West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited. (Service of corrected image is attached). (Shaffer, Wayne) (Entered: 03/08/2017) (0) |
| Mar 7, 2017 | 62 | MINUTE ORDER IN CHAMBERS of the Honorable Judge Miranda M. Du, on 3/7/2017. By Deputy Clerk: Peggie Vannozzi. Petitioner Alan B. Clement did not answer question number 5 of his Verified Petition (ECF No. 56 .) Petitioner is directed to provide an answer to question number 5 and resubmit his Verified Petition, using the event "Notice of Corrected Image" and linking the notice to the original Petition. (no image attached) (Copies have been distributed pursuant to the NEF - PAV) (Entered: 03/07/2017) (0) |
| Mar 7, 2017 | 63 | ORDER granting ECF No. 58 Verified Petition for Permission to Practice Pro Hac Vice as to Jennifer M. Coronel on behalf of West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited and approving Designation of Local Counsel Wayne A. Shaffer. Signed by Judge Miranda M. Du on 03/06/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KW) (Entered: 03/07/2017) (0) |
| Mar 7, 2017 | 64 | ORDER granting ECF No. 57 Verified Petition for Permission to Practice Pro Hac Vice as to Myoka Kim Goodin on behalf of West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited and approving Designation of Local Counsel Wayne A. Shaffer. Signed by Judge Miranda M. Du on 03/06/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KW) (Entered: 03/07/2017) (0) |
| Mar 7, 2017 | 65 | ORDER granting ECF No. 59 Verified Petition for Permission to Practice Pro Hac Vice as to Nina Vachhani on behalf of West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited and approving Designation of Local Counsel Wayne A. Shaffer. Signed by Judge Miranda M. Du on 03/06/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KW) (Entered: 03/07/2017) (0) |
| Mar 3, 2017 | 56 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Alan B. Clement and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-4504900) filed by Defendants West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited . (Shaffer, Wayne) (Entered: 03/03/2017) (0) |
| Mar 3, 2017 | 57 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Myoka Kim Goodin and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-4504943) filed by Defendants West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited . (Shaffer, Wayne) (Entered: 03/03/2017) (0) |
| Mar 3, 2017 | 58 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Jennifer M. Coronel and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-4505000) filed by Defendants West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited . (Shaffer, Wayne) (Entered: 03/03/2017) (0) |
| Mar 3, 2017 | 59 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Nina Vachhani and DESIGNATION of Local Counsel Wayne A. Shaffer (Filing fee $ 250 receipt number 0978-4505036) filed by Defendants West-Ward Pharmaceuticals Corporation, West-Ward Pharmaceuticals International Limited . (Shaffer, Wayne) (Entered: 03/03/2017) (0) |
| Mar 3, 2017 | 60 | SCHEDULING ORDER pursuant to ECF No. 55 Proposed Discovery Plan/Scheduling Order. See order for specific deadlines. Signed by Magistrate Judge Nancy J. Koppe on 03/03/2017. (Copies have been distributed pursuant to the NEF - KW) (Entered: 03/06/2017) (0) |
| Mar 3, 2017 | 61 | NOTICE PURSUANT TO LOCAL RULE IB 2-2: In accordance with 28 USC § 636(c) and FRCP 73, the parties in this action are provided with a link to the "AO 85 Notice of Availability, Consent, and Order of Reference - Exercise of Jurisdiction by a U.S. Magistrate Judge" form on the Court's website - www.nvd.uscourts.gov. AO 85 Consent forms should NOT be electronically filed. Upon consent of all parties, counsel are advised to manually file the form with the Clerk's Office. (A copy of form AO 85 has been mailed to parties not receiving electronic service.)NOTICE OF GENERAL ORDER 2013-1 AND OPPORTUNITY FOR EXPEDITED TRIAL SETTING: The parties in this action are provided with a link to General Order 2013-1 and the USDC Short Trial Rules on the Court's website - www.nvd.uscourts.gov. If the parties agree that this action can be ready for trial within 180 days and that a trial of this matter would take 3 days or less, the parties should consider participation in the USDC Short Trial Program. If the parties wish to be considered for entry into the Court's Short Trial Program, they should execute and electronically file with USDC Short Trial Form 4(a)(1) or Form 4(a)(2). (no image attached) (KW) (Entered: 03/06/2017) (0) |
| Mar 2, 2017 | 55 | PROPOSED Discovery Plan/Scheduling Order filed by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited Stipulated Discovery Plan and Scheduling Order. (Smith, Jason) (Entered: 03/02/2017) (0) |
| Feb 28, 2017 | 54 | (1st Notice) Pursuant to Local Rule IC 2-1: that Constance S. Huttner is in violation of Local Rule IC 2-1. Participation in the electronic filing system became mandatory for all attorneys effective January 1, 2006. You are required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) program and the electronic service of pleadings. Please visit the Court's website to register for CM/ECF. (no image attached) (DRM) (Entered: 02/28/2017) (0) |
| Feb 27, 2017 | 53 | ORDER approving ECF No. 51 Stipulation to Extend Time to File Verified Petitions for Permission to Practice Pro Hac Vice and Designation of Local Counsel (First Request). Petitions and Designation of Local Counsel due by 3/10/2017. Signed by Judge Miranda M. Du on 02/27/2017. (Copies have been distributed pursuant to the NEF - KW) (Entered: 02/27/2017) (0) |
| Feb 24, 2017 | 52 | ORDER approving ECF No. 50 Stipulation Substituting West-Ward Pharmaceuticals Corp and West-Ward Pharmaceuticals International Limited as Defendants and Counterclaim Plaintiffs Pursuant to Fed. R. Civ. P. 25(C). Signed by Magistrate Judge Nancy J. Koppe on 2/24/2017. (Copies have been distributed pursuant to the NEF - KR) (Entered: 02/24/2017) (0) |
| Feb 23, 2017 | 50 | STIPULATION and Order Substituting West-Ward Pharmaceuticals Corp. and West-Ward Pharmaceuticals International Limited as Defendants and Counterclaim Plaintiffs Pursuant to Fed. R. Civ. P. 25(C) by Defendants Hikma Pharmaceuticals PLC, Roxane Laboratories, Inc.. (Shaffer, Wayne) (Entered: 02/23/2017) (0) |
| Feb 23, 2017 | 51 | STIPULATION and Order to Extend Time to File Verified Petitions for Permission to Practice Pro Hac Vice and Designation of Local Counsel by Defendants Hikma Pharmaceuticals PLC, Roxane Laboratories, Inc.. (Shaffer, Wayne) (Entered: 02/23/2017) (0) |
| Feb 21, 2017 | 49 | ANSWER to 38 Answer to Complaint, Counterclaim Answer to Defendant's Counterclaims filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.(Santoro, Nicholas) (Entered: 02/21/2017) (0) |
| Feb 7, 2017 | 47 | ORDER approving ECF No. 45 Verified Petition for Permission to Practice Pro Hac Vice by Constance S. Huttner for Dr. Reddy's Labs Inc and Dr. Reddy's Labs Ltd, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 2/7/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 02/07/2017) (0) |
| Feb 7, 2017 | 48 | ORDER approving ECF No. 46 Verified Petition for Permission to Practice Pro Hac Vice by Caroline Sun for Dr. Reddy's Labs Inc and Dr. Reddy's Labs Ltd, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 2/7/2017. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 02/07/2017) (0) |
| Feb 6, 2017 | 45 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Constance S. Huttner and DESIGNATION of Local Counsel Michael D. Rounds (Filing fee $ 250 receipt number 0978-4466895) filed by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. . (Rounds, Michael) (Entered: 02/06/2017) (0) |
| Feb 6, 2017 | 46 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Caroline Sun and DESIGNATION of Local Counsel Michael D. Rounds (Filing fee $ 250 receipt number 0978-4466933) filed by Counter Claimants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. . (Rounds, Michael) (Entered: 02/06/2017) (0) |
| Feb 3, 2017 | 43 | ORDER granting ECF No. 42 STIPULATION : Proposed Discovery Plan/Scheduling Order due by 3/2/2017. Signed by Magistrate Judge Nancy J. Koppe on 2/3/2017. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 02/03/2017) (0) |
| Feb 3, 2017 | 44 | ANSWER to 33 Answer to Complaint,, Counterclaim, Answer to Defendants' Counterclaims filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.(Santoro, Nicholas) (Entered: 02/03/2017) (0) |
| Feb 2, 2017 | 42 | STIPULATION FOR EXTENSION OF TIME (First Request) Stipulation and Order to Extend Time to File Proposed Scheduling Order by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited, Counter Defendants Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Smith, Jason) (Entered: 02/02/2017) (0) |
| Jan 31, 2017 | 41 | NOTICE TO COUNSEL PURSUANT TO LOCAL RULE IA 11-2. Counsel J.C. Rozendaal, Esq. and Michael E. Joffre, Esq. to comply with completion and electronic filing of the Designation of Local Counsel and Verified Petition. For your convenience, click on the following link to obtain the form from the Court's website - www.nvd.uscourts.gov/Forms.aspx. Upon approval of the Verified Petition, counsel is required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) system and the electronic service of pleadings. Please visit the Court's website www.nvd.uscourts.gov to register Attorney(s). Verified Petition due by 3/17/2017. (no image attached) (BLG) (Entered: 01/31/2017) (0) |
| Jan 30, 2017 | 37 | ANSWER to 27 Answer to Complaint,,, Counterclaim,, Answer to Defendants' Counterclaims filed by Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited.(Santoro, Nicholas) (Entered: 01/30/2017) (0) |
| Jan 30, 2017 | 38 | ANSWER to 1 Complaint,,, with Jury Demand ANSWER TO COMPLAINT AND COUNTERCLAIM, COUNTERCLAIM against Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited filed by Teva Pharmaceuticals USA, Inc..(Mercera, Maria) (Entered: 01/30/2017) (0) |
| Jan 30, 2017 | 39 | CERTIFICATE of Interested Parties filed by Teva Pharmaceuticals USA, Inc. that identifies all parties that have an interest in the outcome of this case. Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA, Inc. added. . (Mercera, Maria) (Entered: 01/30/2017) (0) |
| Jan 30, 2017 | 40 | NOTICE of Corrected Image/Document re 38 Answer to Complaint, Counterclaim by Defendant Teva Pharmaceuticals USA, Inc., Counter Claimant Teva Pharmaceuticals USA, Inc.. (Service of corrected image is attached). (Mercera, Maria) (Entered: 01/30/2017) (0) |
| Jan 25, 2017 | 36 | ORDER approving ECF No. 35 , Stipulation and [Proposed] Order (1) Dismissing Teva Pharmaceutical Industries Ltd. without Prejudice; and (2) Extend the Time for Teva Pharmaceuticals USA, Inc. to Answer or otherwise respond. Teva Pharmaceutical Industries Limited (from Member Case 2:16-cv-02658-MMD-GWF) terminated. Teva Pharmaceuticals USA, Inc. answer is due 1/30/2017. Caption in 2:16-cv-2658-MMD-NJK to be amended to read Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited vs. Teva Pharmaceuticals USA, Inc. Signed by Judge Miranda M. Du on 1/25/2017. (Copies have been distributed pursuant to the NEF - PAV) (Entered: 01/25/2017) (0) |
| Jan 23, 2017 | 34 | WAIVER OF SERVICE Returned Executed by Amarin Pharmaceuticals Ireland Limited, Amarin Pharma, Inc.. Teva Pharmaceuticals USA, Inc. waiver sent on 11/22/2016, answer due 1/21/2017. (Santoro, Nicholas) (Entered: 01/23/2017) (0) |
| Jan 23, 2017 | 35 | STIPULATION FOR EXTENSION OF TIME (First Request) re 1 Complaint,,, ; Stipulation and [Proposed] Order (1) Dismissing Teva Pharmaceutical Industries Ltd. without Prejudice; and (2) Extend the Time for Teva Pharmaceuticals USA, Inc. to Answer or Otherwise Respond to the Complaint in Original Case No.: 2:16-cv-02658-MMD-NJK by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. (Santoro, Nicholas) (Entered: 01/23/2017) (0) |
| Jan 13, 2017 | 33 | ANSWER to 1 Complaint,,, Original Case No.: 2:14-cv-02562, COUNTERCLAIM against Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited filed by Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Attachments: # 1 Exhibit A)(Rounds, Michael) (Entered: 01/13/2017) (0) |
| Jan 10, 2017 | 29 | NOTICE TO COUNSEL PURSUANT TO LOCAL RULE IA 11-2. Counsel Alan B. Clement; Myoka Kim Goodin; Nina Vachhani; and Jennifer Coronel to comply with completion and electronic filing of the Designation of Local Counsel and Verified Petition. For your convenience, click on the following link to obtain the form from the Court's website - www.nvd.uscourts.gov/Forms.aspx. Upon approval of the Verified Petition, counsel is required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) system and the electronic service of pleadings. Please visit the Court's website www.nvd.uscourts.gov to register Attorney(s). Verified Petition due by 2/24/2017. (no image attached) (BLG) (Entered: 01/10/2017) (0) |
| Jan 10, 2017 | 30 | ORDER to Consolidate - Clerk of Court is directed to transfer Case No. 2:16-cv-02562-RCJ-GWF to District Judge Miranda M. Du and Magistrate Judge Nancy J. Koppe. It is further ordered that the Clerk of Court is directed to consolidate Case Nos. 2:16-cv-02562-RCJ-GWF and 2:16-cv-02658-MMD-GWF with Case No. 2:16- cv-02525-MMD-NJK and all future pleadings must bear Case No. 2:16-cv-02525-MMD-NJK. Signed by Judges Miranda M. Du and Robert C. Jones on 1/10/2017. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/10/2017) (0) |
| Jan 10, 2017 | 31 | ORDER APPROVING Verified Petition for Permission to Practice Pro Hac Vice of Attorney Megan P. Keane (ECF No. 21 in Member Case 2:16-cv-2562) for Amarin Pharma, Inc. & Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Judge Miranda M. Du on 1/10/2017. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/10/2017) (0) |
| Jan 10, 2017 | 32 | ORDER APPROVING Verified Petition for Permission to Practice Pro Hac Vice of Attorney Michael N. Kennedy (ECF No. 22 in Member Case 2:16-cv-2562) for Amarin Pharma, Inc. & Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Judge Miranda M. Du on 1/10/2017. (Copies have been distributed pursuant to the NEF - DRM) (Entered: 01/10/2017) (0) |
| Jan 9, 2017 | 27 | ANSWER to 1 Complaint,,, Affirmative Defenses (, Discovery Plan/Scheduling Order due by 2/23/2017.), COUNTERCLAIM against All Plaintiffs filed by Hikma Pharmaceuticals PLC, Roxane Laboratories, Inc..(Shaffer, Wayne) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. (Entered: 01/09/2017) (0) |
| Jan 9, 2017 | 28 | CERTIFICATE of Interested Parties filed by Hikma Pharmaceuticals PLC, Roxane Laboratories, Inc. that identifies all parties that have an interest in the outcome of this case. Other Affiliate West-Ward Pharmaceuticals Corporation, Other Affiliate West-Ward Pharmaceuticals International Limited, Other Affiliate HIK.L for Hikma Pharmaceuticals PLC, Hikma Pharmaceuticals PLC, Roxane Laboratories, Inc., Roxane Laboratories, Inc. added. . (Shaffer, Wayne) (Entered: 01/09/2017) (0) |
| Jan 5, 2017 | 26 | NOTICE NON-OPPOSITION to 25 Motion to Consolidate by Hikma Pharmaceuticals PLC, Roxane Laboratories, Inc.. (Shaffer, Wayne) Modified on 1/6/2017 event correction & link added. (BLG). (Entered: 01/05/2017) (0) |
| Dec 22, 2016 | 25 | MOTION to Consolidate Cases Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited's Motion to Consolidate by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited. Responses due by 1/5/2017. (Attachments: # 1 Certificate of Service)(Santoro, Nicholas) (Entered: 12/22/2016) (0) |
| Dec 9, 2016 | 24 | ORDER approving ECF No. 23 Verified Petition for Permission to Practice Pro Hac Vice by Michael N. Kennedy for Amarin Pharma Inc and Amarin Pharmaceuticals Ireland Ltd, and approving Designation of Local Counsel. Signed by Judge Miranda M. Du on 12/9/2016. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - KR) (Entered: 12/09/2016) (0) |
| Dec 8, 2016 | 23 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Michael N. Kennedy and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-4393107) filed by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited . (Santoro, Nicholas) (Entered: 12/08/2016) (0) |
| Dec 7, 2016 | 22 | ORDER APPROVING ECF No. 21 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Megan P. Keane for Amarin Pharma, Inc. & Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Judge Miranda M. Du on 11/6/2016. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - DRM) (Entered: 12/07/2016) (0) |
| Dec 5, 2016 | 21 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Megan P. Keane and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-4388899) filed by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited . (Santoro, Nicholas) (Entered: 12/05/2016) (0) |
| Nov 30, 2016 | 19 | ORDER APPROVING ECF No. 16 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Christopher N. Sipes for Amarin Pharma, Inc., & Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Santoro. Signed by Judge Miranda M. Du on 11/29/2016. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - DRM) (Entered: 11/30/2016) (0) |
| Nov 30, 2016 | 20 | ORDER APPROVING ECF No. 18 Verified Petition for Permission to Practice Pro Hac Vice of Attorney Einar Stole for Amarin Pharma, Inc. & Amarin Pharmaceuticals Ireland Limited, and approving Designation of Local Counsel Nicholas J. Snatoro. Signed by Judge Miranda M. Du on 11/29/2016. Any Attorney not yet registered with the Court's CM/ECF System shall submit a Registration Form on the Court's website www.nvd.uscourts.gov (Copies have been distributed pursuant to the NEF - DRM) (Entered: 11/30/2016) (0) |
| Nov 29, 2016 | 18 | VERIFIED PETITION for Permission to Practice Pro Hac Vice by Einar Stole and DESIGNATION of Local Counsel Nicholas J. Santoro (Filing fee $ 250 receipt number 0978-4380399) filed by Plaintiffs Amarin Pharma, Inc., Amarin Pharmaceuticals Ireland Limited . (Santoro, Nicholas) (Entered: 11/29/2016) (0) |
| Nov 2, 2016 | 1 | Main Document (33) |
| Nov 2, 2016 | 1 | Civil Cover Sheet (1) |
| Nov 2, 2016 | 1 | Main Document (33) |
| Nov 2, 2016 | 2 | Appendix (2) |
| Nov 2, 2016 | 1 | Civil Cover Sheet (1) |
| Nov 2, 2016 | 3 | Exhibit A (12) |
| Nov 2, 2016 | 2 | Appendix (2) |
| Nov 2, 2016 | 4 | Exhibit B (22) |
| Nov 2, 2016 | 3 | Exhibit A (12) |
| Nov 2, 2016 | 5 | Exhibit C (23) |
| Nov 2, 2016 | 4 | Exhibit B (22) |
| Nov 2, 2016 | 2 | Certificate of Interested Parties (2) |
| Nov 2, 2016 | 6 | Exhibit D (22) |
| Nov 2, 2016 | 5 | Exhibit C (23) |
| Nov 2, 2016 | 7 | Exhibit E (23) |
| Nov 2, 2016 | 6 | Exhibit D (22) |
| Nov 2, 2016 | 8 | Exhibit F (23) |
| Nov 2, 2016 | 7 | Exhibit E (23) |
| Nov 2, 2016 | 9 | Exhibit G (23) |
| Nov 2, 2016 | 2 | Certificate of Interested Parties (2) |
| Nov 2, 2016 | 8 | Exhibit F (23) |
| Nov 2, 2016 | 10 | Exhibit H (24) |
| Nov 2, 2016 | 9 | Exhibit G (23) |
| Nov 2, 2016 | 11 | Exhibit I (24) |
| Nov 2, 2016 | 10 | Exhibit H (24) |
| Nov 2, 2016 | 12 | Exhibit J (23) |
| Nov 2, 2016 | 11 | Exhibit I (24) |
| Nov 2, 2016 | 13 | Exhibit K (23) |
| Nov 2, 2016 | 12 | Exhibit J (23) |
| Nov 2, 2016 | 14 | Exhibit L (23) |
| Nov 2, 2016 | 13 | Exhibit K (23) |
| Nov 2, 2016 | 15 | Exhibit M (24) |
| Nov 2, 2016 | 14 | Exhibit L (23) |
| Nov 2, 2016 | 16 | Exhibit N (23) |
| Nov 2, 2016 | 15 | Exhibit M (24) |
| Nov 2, 2016 | 17 | Exhibit O (31) |
| Nov 2, 2016 | 16 | Exhibit N (23) |
| Nov 2, 2016 | 17 | Exhibit O (31) |
| Oct 31, 2016 | N/A | Case assigned to Judge Jennifer A. Dorsey and Magistrate Judge Nancy J. Koppe. Nature of Suit: 830 Patent Case (DL) (Entered: 11/01/2016) (0) |
